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Abstract  
National health organisations and authorities have reported an increment in death 
cases due to cancer. To overcome this issue and improve the survival rate, it is needed 
to find new clinical methods, early diagnoses techniques and treatments. Radiation and 
chemotherapy have been used for years to treat cancer. However, these types of 
treatments have serious side effects such as hair loosing, the mortality of healthy cells 
and other organs. A new treatment based on prodrugs therapy is in development with 
the intention to reduce these side effects or to replace the harmful treatments 
completely. Prodrug treatments need an activation agent, i.e. a catalyst, to convert the 
prodrug delivered to the cancerous cells to an active drug in-situ. Metals such as 
palladium can be used as a catalyst to activate the prodrug in targeted cancer cells.  
In this PhD study, the research was divided into two major aspects. The first aspect 
was to design and manufacture a catalyst carrier with specific properties and 
specifications such as biocompatibility of the materials used as the carrier, suitable 
mechanical properties to withstand physiological loads and conditions, and cost 
efficiency of the production. Two different manufacturing methods were used, Powder 
Metallurgy technique and Arc Melting technique, to achieve the optimal fabrication 
method. The carriers were characterised via XRD, SEM, EDS, DSC methods and 
mechanical tests to ensure the carrier meets the requirements. In the second stage, the 
carriers were coated with Palladium in its metallic state (i.e. Pd0). The coating was 
required to meet the requirements of being unalloyed, pure and free of any 
contamination, and its deposition cost and time effective. Four coating methods were 
employed. Powder Metallurgy technique and sintering (with and without space 
holder), Magnetron Sputtering, Pulsed Laser Deposition and Supersonic Beam Cluster 
Deposition methods were used to apply Palladium coating onto the carriers. The 
coating was characterised by XPS, XRD, FIB, XRF, SEM, EDS, biochemical and in-situ 
biological tests.  
The results obtained confirmed that the devices achieve high biocompatibility of 
the materials, and an excellent superelasticity can withstand the loads inside the 
human body. Also, the Magnetron sputtering methods as a coating method 
demonstrated it is the most effective for achieving a uniform and long-lasting 
deposited layer. The devices were able to activate a clinically approved prodrug.
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Abbreviations and symbols 
3DP Additive manufacturing GPa Gigapascal 
DED Directed energy deposition °C Celsius degree 
CAD Computer-aided drawing kN Kilonewton 
PBF Powder bed fusion mm millimetre 
MIM Metal injection moulding nm nanometre 
PM Powder metallurgy technique N Newton 
SP Magnetron sputtering 
deposition 
Pd0 Palladium in its unalloyed state 
PLD Pulsed laser deposition Ti Titanium  
SCBD Supersonic cluster beam 
deposition 
Sn Tin 
S Sintered wafers Nb  Niobium  
Sx Sintered samples with space 
holder 
Ta Tantalum 
Sc  Sintered samples with carrier NaCl Sodium chloride 
EDS Energy dispersive x-ray 
spectrometry  
As Austenite start temperature 
SEM Scanning electron microscope Af Austenite finish temperature 
XPS X-ray photoelectron 
spectroscopy 
Ms Martensitic start 
transformation temperature 
DSC Differential scanning 
calorimetry 
Mf Martensitic finish temperature 
XRD X-ray diffraction hcp Hexagonal closed pack 
PLD Pulsed laser deposition bcc Body centred cubic 
XRF X-ray fluorescence α Alpha phase 
FIB Focused ion beam  β Beta phase 
θ Is the angle of both incidence 
and reflection 
CIP Cold isostatic pressing  
λ Wavelength of the illuminating 
x-rays 
%wt Percent in weight 
SD Standard deviation BH Before heat treatment 
π Pie = 3.14 AH After heat treatment 
ρ Density   
M Mass   
F Force   
A Area    
V Volume   
r Radius   
D Diameter   
h Height   
mbar Millibar pressure unit   
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1 Introduction 
1.1 Background 
The number of death cases due to cancer has increased because of the lack of 
effective treatments that can increase survival rates. Based on the American Cancer 
Society Report, the number of the new cancer cases increased from 1,372,910 cases to 
1,688,780 and the death cases from 570,280 to 600,920 between 2005 and 2007 (1,2). 
In its most updated edition, the report presented an obvious increment in new cancer 
diagnoses to 1,735,350 cases and 609,640 cancer death cases in 2018 (3). The most 
common types of cancer reported were prostate, colon and lung cancer for men while 
lung, breast and colorectal cancer for women (4,5). Bone cancer in both genders was 
also mentioned. In Europe, the diagnosed cancer cases were 2,886,800 cases and 
1,711,000 cases of death in 2004. Lung cancer was the most frequent cause of cancer 
death among others such as breast and colon cancers (6). In 2006, the number of 
cancer cases diagnosed in Europe increased to 3,191,600 (7) and increased further in 
2012 to 3,450,000 cases (8). While in 2018, the number of cancer cases estimated to 
reach 3,910,000 cases and 1,930,000 death cases (9). Advances in medical and cancer 
treatment are urgently needed to address this significant public health issue.  
Chemotherapy and radiation therapy have been used for years as the only 
treatment for cancer. This kind of treatment targets cancer cells as well as healthy cells. 
Therefore, patients experience life-changing side effects such as hair loss, weakness 
and effects on other organs. In an attempt to overcome these issues, new cancer 
treatments have been introduced such as photodynamic therapy (10), monoclonal 
antibody therapy (11,12), immunotherapy (13), proton therapy (14,15) and prodrugs 
therapy (16). 
Prodrugs therapies need an activation agent that can convert a prodrug (i.e. an 
inactive compound) into an active drug that creates a toxic environment for the 
cancerous cells and eliminates them. The use of implantable devices that delivers drugs 
at a controlled rate to the targeted area has already been reported. However, these 
devices become depleted of the drug in time and become inert very shortly after the 
therapy has commenced. A novel approach proposed is to implant a device loaded with 
a catalyst that does not get consumed in the reaction, so its activity is sustained for as 
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long as the cancer treatment lasts (17). An implantable metal device can be used as a 
catalyst to activate the prodrug in a specific anatomical location to limit the effect of 
the drug in the desired area without affecting other healthy tissues. In this research, 
Pd0 was chosen as the catalyst metal to benefit from the wealth of prodrugs that can 
be activated by Palladium metal (17-20) as shown in Figure 1-1.  
 
Figure 1-1: Strategy for the intratumoral activation of inactive prodrug into 
cytotoxic drugs via catalyst-loaded carriers 
A substrate for this catalyst needs to be selected attending to the implantation 
location in the human anatomy. While soft tissues and internal organs (e.g. lungs, 
pancreas, breast, etc.) are less constraining in the material’s performance 
specifications, load-bearing sites (i.e. bones) require the substrate to act as a 
multifunctional material. Not only serving as the carrier of the catalyst and of 
biocompatible nature, it also needs to sustain the loads upon the bone. A much sought-
after property in this regard is superelasticity, a peculiar characteristic of bone that 
promotes cell osteointegration regeneration, as well as durability to wearing and 
fatigue in long term cyclic use.  
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The fabrication of a device using biocompatible materials loaded with Palladium, 
that can be implanted in the cancerous organ, and is easily removed after the 
treatment, is the main purpose of this research. The shape and the dimensions of the 
device to be adequate to be handled by surgeons is also a consideration. To put it 
simply, the device has to fulfil the following requirements: 
i. The palladium coating and the substrate elements should not be alloyed 
together. The palladium has to be retained in its metallic form (Pd0) 
ii. Minimum mass of palladium should be used. 
iii. The process has to produce highly uniform coatings. 
iv. The coating must be free from toxic constituents and be of high purity 
of the metallic surface since metallic Pd0 is required to be the final 
coating material to undergo biochemical reactions. 
v. All materials used in this research have to be biocompatible materials. 
vi. The process is required to be time and cost effective.  
vii. Its shape and dimensions have to be suitable for the handling in the 
operating theatre by the surgeons and medics, both when implanting 
and after the treatment when removing it. It needs to avoid leaving 
loose Pd in the human body. 
viii. The device should display mechanical properties that make it 
compatible for implantation into bone, i.e., similar stiffness and 
superelasticity.      
1.2 Suitable Carrier 
A biomaterial was defined by Williams in 1999 as: “a material intended to interface 
with biological systems to evaluate, treat, augment, or replace any tissue, organ, or 
function of the body” (21,22). However, the definition of a biomaterial has changed 
over the years with the progress in science and research. By discovering more 
applications and limitations of the biomaterials, the definition of biomaterials changed 
to update it with the recent findings (23,24) and describe properties beyond being an 
inert substance.  
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The need of a suitable carrier to deploy the catalyst (palladium in this case) to the 
cancerous tissues requires a metallic biomaterial such as Titanium (Ti) since Ti is a 
biocompatible material.    
1.2.1 Metallic Implants 
Metallic implants were introduced into the medical field in the 19th century and 
developed alongside progress in the metal industry (25,26). Bone implants are an 
obvious example of metal implant in the human body (27) such as hip replacement 
(28,29), knee replacement (30) and other bone replacements. Metallic biomaterials 
such as stainless-steel and cobalt alloys and titanium have been used for years to 
replace the failed hard tissues (31). Oral implants are available to replace teeth or to 
fix a medical issue. They are available in different shapes, materials, dimensions, 
surface properties and coatings. Several modifications of the metal surfaces have been 
applied on materials to enhance their clinical performance (32). That development 
includes turning, blasting, acid-etching, porous sintering, oxidising, plasma spraying, 
hydroxyapatite coated surfaces, and a combination of all these processes. There are 
more than 1300 types of implants that the surgeons and dentists can choose from.  
1.2.2 Titanium and Titanium alloys  
Titanium and its alloys are considered as one of the most important materials for 
biomedical applications (33). Well-known examples of using titanium and its alloys in 
medical devices are artificial hearts valves, knee and hip joints (34), screws for fracture 
fixation and cardiac valves for long term or permanent implants (35). Also, titanium 
alloys are used for dental applications either for external and temporary medical 
applications such as dental braces which can be removed after the treatment or for 
permanent replacement of missing tooth (36-38). They are taken into consideration 
due to their promising properties such as corrosion resistance (39), formability, 
machinability, low modulus, ductility and fatigue strength (40). In addition, Titanium 
and its alloys show excellent biocompatibility. Furthermore, the ability of the titanium 
alloys to mimic the mechanical properties of bones by adjusting their mechanical 
properties via the addition of the desirable alloying elements (41) is a major 
advantage. Also, an important reason to use Titanium as a carrier in this research is 
the ability to detect the device in the human body via X-Ray and MRI scanning due to 
the good contrast of the material against the tissue. That will help to implant and 
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remove the device from the human body easily by the surgeons after the treatment has 
been completed, as mentioned in section 1.2 as one of the requirements to find the 
suitable carrier material.   
1.3 Bioorthogonal Chemistry 
Bioorthogonal reactions are those that happen inside a life system without 
interference with concurrent reactions (42,43). Such reaction is compatible with the 
biological environment and enables the chemical reaction of the cells within their 
native environment (44,45). These reactions were invented to monitor physiological 
and pathological processes and can be mediated by two or more mutually-reactive 
chemical groups or in combination with transition metals. Several transition metals 
have been used such as Cu (46,47), Au(48), Ru (49,50), or Pd (51,52). These transition 
metals can be used as catalysts to complete the biorthogonal reaction within a specific 
location inside a living system.    
1.4 Objectives 
The objective of this research was to create a medical device that could be 
implanted in the human body to activate a prodrug in situ. The material had to be 
biocompatible and easy to be manufactured through mass production routes. The 
device was manufactured using Titanium and its alloys as the carrier due to its 
biocompatibility and desired mechanical performance and Palladium as the transition 
metal used in the bioorthogonal reactions as the catalyst. In addition, the device had to 
have mechanical properties suitable to withstand the stress and loads once implanted 
in the human body. Furthermore, it had to have a good corrosion resistance and had to 
be of adequate size to be implanted and removed from the human body through 
keyhole surgeries.      
 Because Palladium (Pd0) is needed to activate the prodrug when they come into 
contact, this needs to be presented in its unalloyed state. Finding a method to make a 
Titanium carrier with Palladium joined together has remained the main challenge in 
the manufacturing of the device.  
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1.5 Contribution to Knowledge  
Through this research, it has been found that the most cost effective and efficient 
way to deposit metallic state, unalloyed Palladium on a Titanium carrier is by the use 
of physical vapour deposition methods. Amongst all the methods surveyed and tested, 
it was an optimised magnetron sputtering method that produced the most resilient, 
pure and active catalyst to trigger the conversion from inactive prodrug into an active 
anticancerous drug.   
Also, this research found out that Ti alloys can be designed and fabricated to 
stabilise β and β+α phases at room temperature and therefore achieve desired 
mechanical properties such as stiffness and superelasticity. This was successfully 
achieved by: 1) adding different β-stabilising alloying element such as Nb, Sn and Ta in 
different proportions; and 2) controlling the post heat-treatment temperature and 
duration.  
1.6 Novelty Statement 
Targeted treatments for cancer have been proposed to eliminate the cancerous 
cells without affecting the healthy cells and reduce the side effects of the other cancer 
treatments. Prodrugs, which are considered as targeted cancer treatments, needs an 
activating agent to convert the prodrug into an active drug. The activation agent needs 
to be made of biocompatible material which can activate the clinically approved 
prodrug and do not consume in the reaction. A novel approach proposed to implant a 
metallic device coated with a catalyst that can trigger the prodrug and removed after 
the treatment completed. However, the area of fabricating a metallic device has not 
been tackled in previous researches. Therefore, this research provides a design of a 
metallic carrier made of Titanium alloy with the specific characterisation that can 
withstand the physical loads inside the human body. Also, an optimal coating method 
can be used to apply a catalyst material (Pd0 in the case). 
This approach is considered as the first step towards a novel class of surgically 
implantable devices that could facilitate targeting affected areas with high spatial 
selectivity, enhanced pharmacological activity and reducing side effects.  
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1.7 Research scope  
The main aim of this research was to activate a prodrug using a metallic medical 
device. The medical device made of a carrier and a catalyst coating. The major factors 
to be considered in this research are: all materials used in the manufacturing process 
of the device has to be biocompatible, able to reduce the transformation temperature 
to be closed the human body temperature, improve the superelasticity of the device to 
withstand the loads and conditions inside the human body, reduce the young modulus 
to be close to the bone’s, produce strong adhesion bond between the carrier and the 
catalyst coating and apply minimal amount of the catalyst material.  
The present research is mainly concerned with the design , fabrication and 
characterisations of  a metallic medical device, consisting of a palladium catalyst 
coating and an underpinning titanium-based carrier structure. For the fabrication of 
Ti-based alloy carrier, the feasibility of both powder metallurgy technique and arc 
melting method have been evaluated, with specific focuses on their suitability to 
render homogeneous and stable β phase titanium alloy. Β stabilisers such as Nb and 
Ta, and Young’s modulus reducer such as Sn , have been added with Ti various 
compositions in attempts to adjust phase metallurgy and microstructures, such as to 
bring out desired mechanical properties (i.e. stiffness and superelasticity). Post 
thermal treatments have been examined to assess their effect on the microstructure 
and mechanical properties. For the application of the catalyst coating onto the Ti alloy 
carrier, a range of thin film deposition methods have been examined. These have 
included sintering, magnetron sputtering deposition, pulsed laser deposition and 
supersonic beam deposition. The microstructural integrity, coating uniformity, 
adhesion of the coating and chemical purity of the resulted coating have been 
characterised using a range of surface and material characterisation methods such as 
SEM,TEM, XPS and compression test. 
The biological tests and the activation level of the manufactured devices have been 
performed in collaboration with the Cancer Research UK Edinburgh Centre, at the 
University of Edinburgh.  
 
 
                            Introduction 
8 
 
1.8 Summary  
In order to research how to manufacture an implanted medical device with 
Titanium or Titanium alloys as a carrier and Palladium as the coating which will 
activate a prodrug when taken orally, a literature review of previous studies on 
medical devices, biomaterials and targeted cancer treatments, as well as 
manufacturing procedures and techniques, was undertaken. Experimental work has 
been done in parallel with the literature review, and it embodies the feasibility study 
presented in this thesis.  
The literature survey informed the selection of the best manufacturing 
methodology based on the requirements stated above and the feasibility of  
manufacturing the samples as simply as possible, with an intention to be 
automated easily in the future, considering the availability of the laboratory facilities, 
the total cost of the manufacturing and the implications of choosing a method over 
another.     
The work was split into 2 parts: 
1. Manufacture and characterisation of the Titanium carrier 
2. Addition and characterisation of the Palladium coating  
Different manufacturing processes for the carrier were evaluated to find the 
optimal fabrication process and eliminate the unpromising processes. Powder 
Metallurgy techniques and Arc Melting processes were opted to be used in this 
research after careful evaluation. Carriers were fabricated with different specifications 
to find the optimal carrier for the device. Several alloying elements were used to 
manufacture biocompatible alloys with the required mechanical properties of 
hardness, stiffness and superelasticity. 
After manufacturing the carrier, catalyst addition processes were evaluated and 
studied. Four deposition methods were applied to create a metallic palladium coating 
on the carrier. The first method involved powder metallurgy, and the Pd was presented 
substrate-less, i.e., a disc of palladium acting as its own carrier. Then, Ti carriers were 
utilised to deposit a layer of palladium with different surface roughness and also a 
porous layer using the space holder method. Sputtering method was applied to deposit 
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a thin film and reduce the thickness of the coating. Another technique used to deposit 
the coating was via pulsed laser deposition. Finally, a method used a supersonic cluster 
beam deposition process to coat the Ti carrier with Pd coating.          
Characterisation methods for the carrier and the catalyst coating included: 
scanning electron microscopy (SEM) to identify the materials included in the samples 
and X-Ray diffraction (XRD) to study the characterisation of the elements in the 
samples. In addition, calculating the surface area of the samples and the distribution of 
the porosity was a major challenge which was achieved using a surface roughness 
measurement machine (Alicona). TEM and FIB methods were used to measure the 
thickness of the coating and to calculate the mass of the palladium deposited on the 
carrier. Furthermore, XRF and AFM were conducted for the same reason and to 
confirm that the thickness desired was successfully achieved.  
The results of all these tests were compiled and compared. As a result, the best 
manufacturing technique that meets the design specification of the device was 
selected.   
This will mark the baseline for continuing research on suitable alternatives to the 
manufacturing process for a controlled porosity, engineered surface area and 
programmed effectiveness on the prodrug for the Ti-[Pd] device. 
1.9 Thesis Outline  
The thesis is divided into seven chapters and an appendix. Chapter one includes 
an introduction of the research and background about the research area. The aim and 
objectives of this research are explained in this chapter. A brief review of this thesis 
chapters is included with an explanation of the thesis structure. Chapter two contains 
evaluated literature review about the different aspects of the research. Different 
methods of manufacturing, fabricating, and coating processes were studied and 
analysed. Also, manufacturing different Titanium alloys were explored. Chapter three 
explains the methodologies and techniques used in this research to fabricate the 
catalyst carrier. Steps and procedures used to perform the experimental work and 
testing of the samples are described in detail. The results obtained in this part of the 
research are presented in this chapter. Chapter four presents the techniques and 
processes used to apply the catalyst on the carrier. Besides, an analysis of the result 
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obtained with different characterisation methods is presented and explained. Chapter 
five presents a general discussion about the results obtained in this research. Also, a 
comparison between the results obtained and the previously published work in the 
same areas of research is presented. Chapter six concludes and summarises the overall 
research. It includes the summary of the methodology used, the experimental work 
and the final results obtained from this research. Chapter seven presents a set of 
suggestions and future work to be considered in the research area to improve the 
results and further the discovery of new substrates and techniques.   
 
• Introduction Chapter 1
• Literature review Chapter2
• Catalyst carrierChapter 3
• Palladium coating deposition Chapter 4
• DiscussionChapter 5
• ConclusionChapter 6
• Future work  Chapter 7
• AppendixA
Figure 1-2: Thesis structure 
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2 Literature Review 
2.1 Introduction 
This chapter includes a review of the literature and the previous work that has 
been done in the research area. Firstly, an overview of titanium and titanium alloys is 
given as they are used as the material for the carrier. An explanation of Ti crystal 
structures and their different phases is offered as well as a review about the effect of 
various alloying elements on the phase metallurgy and microstructures of Ti alloys. 
This paves the way for designing carrier alloy composition and heat treatment regimes. 
The following section includes a survey of the manufacturing processes that could be 
used to fabricate the Ti alloys.  The advantages and downsides of each approach will 
be discussed with a treatment of their suitability for the fabrication of the Ti alloy 
carrier structure. Finally, a review section contains the coating processes that could be 
used to apply a thin film of palladium onto the Ti carrier.         
2.2 Titanium 
2.2.1 History of Titanium  
There is an ample amount of Titanium in the earth’s crust of about 0.6% which 
makes it considered as one of the most available metals after aluminium, iron and 
magnesium. In 1791, a mineralogist from the UK called Reverend William Gregor found 
a magnetic iron-sand. It was an unknown element in that time. In 1795 another chemist 
from Germany called Martin Heinrich Klaproth investigated rutile brought from 
Hungary and recognised an oxide of an unknown element. He named this unknown 
element Titanium after the powerful sons of the earth in Greek Mythology, Titans (53), 
but it was not introduced and utilised in the industry until 1830’s when the German 
scientist Whilhem Kroll managed to find a successful procedure to extract Titanium. 
Still, the process he created was able to produce a porous metallic sponge of Titanium 
which needed to be purified, grounded and pressed before it can be used as raw 
material(54).  
In 1950s, Titanium and Titanium alloys were investigated and tested to be used in 
different sectors such as aerospace, power and energy plants, chemical industries and 
medical prostheses (55). However, the Titanium alloys were not introduced widely in 
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manufacturing biomedical devices until 1980’s.  It became an important material for 
biomedical devices and implants due to its biocompatibility in the first place and also 
other important reasons, for example, high wearing and low corrosion, outperforming 
stainless steel and Co-Cu alloys (40,55).  
2.2.2  Material structure of Titanium 
Titanium in its pure form has a hexagonal closed pack (HCP) crystal structure at 
room temperature (53). This crystal structure is called alpha phase (α) and it is the 
only phase stable at room temperature. The alpha phase transforms completely into 
beta phase (β), which has a body centred cubic (BCC) crystal structure, above 882˚C. β 
phase remains stable from the transformation temperature up to the melting point of 
Titanium which is around 1678˚C (26,56). However, the exact transformation 
temperature is strongly dependent on the titanium material purity. Figure 2-1(a) and 
(b) exhibit alpha phase (α) crystal structure and beta phase (β) crystal structure 
respectively.   
  
 
Figure 2-1: a) Unit cell of α phase, b) Unit cell of β phase (53) 
2.2.3 Titanium alloys  
The phase stability is influenced by the elements added to it. Titanium is well known 
for the titanium oxide film grown on the surface of the metal to inertisise it. The 
existence of the oxygen on the surface of the metal is one of the reasons that makes the 
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pure titanium have an alpha phase (α) crystal structure at room temperature since 
oxygen is considered an alpha phase (α) stabiliser. In addition, there are different alpha 
phase (α) stabilisers elements that can be used based on the applications and uses of 
the material. Al, N, C as well as O are considered as alpha phase stabilisers. These 
elements when added to titanium alloys increase the beta phase (β) transformation 
temperature. On the other hand, there are some elements considered as beta phase (β) 
stabilisers. They help to stabilise the beta phase (β) at room temperature. 
Furthermore, these elements decrease the beta transformation temperature when 
added to the titanium alloy. Beta phase stabilisers elements include Mo, V, Nb, Ta, Mn, 
Fe, Cr, Co, Ni and Cu, as shown in Figure 2-2. 
The percentage of each element and how many elements will be added to the alloy 
depend on the uses and the application for the alloy. Alloys made with only two 
elements are called binary alloys. These alloys have different properties to the pure 
materials on their own. Furthermore, the percentage of each element changes the 
properties and the crystal structure of the alloy. However, increasing the amount of the 
elements in the alloy may change the overall properties significantly. So, adding a third 
element can help to readjust the properties of the alloys. These alloys are called ternary 
alloys. Adding a third element to the alloy could improve and modify the properties of 
the alloy. Other factors have to be considered to choose the required elements to 
manufacture the alloy such as mechanical properties, biocompatibility, corrosion 
resistance and any other requirements. In this research the main factors that have to 
be considered are: being biocompatible elements, reduce the β transformation 
temperature and improve the superelasticity of the alloy, adding one or more elements 
to the alloy and applying an appropriate heat treatment to improve the properties of 
the alloy to reach the optimal properties required for the medical device (57). 
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Figure 2-2: α and β stabiliser groups (57).  
The transformation from alpha phase (α) to beta phase (β) starts at a temperature 
which is called austenite start temperature (As) and finishes at austenite finish 
temperature (Af). Austenitic transformation happens when the material is heated from 
a low temperature to a temperature around 882˚C. On the other hand, if the material 
is cooled down from a high temperature rapidly to a low temperature through a 
martensitic transformation, temperature starts at martensitic transformation 
temperature (Ms) and finishes at martensitic finish temperature (Mf) (58), as shown in 
Figure 2-3. 
 
Figure 2-3: Thermal phase transformation (58) 
On the other hand, the transformation of β phase Ti alloys start at martensitic start 
temperature (Ms) and finishes at martensitic finish temperature (Mf) as shown in 
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Figure 2-4. The transformation occurs from β phase to either α’ phase or α” phase 
depending on the alloying elements composition added to the alloy (59).   
 
Figure 2-4: Thermal phase transformation for β Ti alloys (modified) (58)   
TiNi alloy was used widely for a long time due to its excellent corrosion resistance, 
superelasticity and shape memory properties for biomedical devices, implants and 
orthopaedics applications (60,61). Though, the toxicity of Ni has been noted in TiNi 
alloys in many studies which justifies the need of Ni-free Titanium alloys (62,63). As a 
result, binary Ni-free beta (β) alloys were developed such as TiNb (64,65), TiTa (66). 
Ternary Ti-based alloys were developed to improve the mechanical properties of 
the alloy. Ti alloys designed with three alloying elements have been used for a long 
time as medical material such as Ti6Al4V(67). However, due to the toxicity of 
Vanadium in the alloy, it was necessary to develop new alloys. Therefore, other alloying 
elements were added to the alloy to replace Vanadium, such as Niobium to fabricate 
the alloy Ti6Al7Nb (57,68-70) and Fe to fabricate Ti5Al2.5Fe (67,71,72). Adding a third 
element to the binary alloys improved and tailored the mechanical properties of the 
alloy to mimic the mechanical properties of the bone.  
Ti-Nb-Sn ternary alloys with 29 different compositions of Ti-(23 to 43)mass%Nb 
and (5 to 15)mass%Sn were produced by Ozaki et al. (73). The study concluded that it 
is possible to reduce the Young’s modulus of TiNbSn alloy to 40 GPa by controlling the 
composition. The compositions of the alloys were designed using the DV-Xα cluster 
method. Also, another study reported that the addition of Sn to Ti30Nb alloy with 
different proportion has a significant effect on the mechanical properties of the alloy 
as well as the phase stabilisation. Sn was added with 2,4,6,8 and 10wt% to the alloy 
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and reduced the formation of ω phase but increased the appearance of β phase. The 
XRD results for these alloys showed α” phase only with the alloys containing 0 or 2wt% 
of Sn while the β phase starts to appear by increasing the percentage of Sn (74) as 
shown in Figure 2-5. Furthermore, the hardness values of the alloys were affected by 
the amount of Sn added. The binary alloy with 0wt% of Sn exhibited the highest 
hardness value around 375HV and started to decrease by increasing the amount of Sn 
to 2 and 4wt% while the alloy with 6wt% showed the lowest hardness value which 
was 210HV and started to increase in the alloys with 8 and 10wt%.    
 
Figure 2-5: XRD results for Ti30NbSn alloys with different Sn content (74)  
A TiNbSn alloy was fabricated using 35wt% of Nb and 2.5,5 and 7.5wt% of Sn by 
Griza et al. The study reported that the alloy Ti35Nb2.5Sn exhibited α” phase while by 
increasing the amount of Sn to 7.5wt% only β phase appeared in the XRD results (75). 
Therefore, Nb and Sn content in TiNbSn alloys has a direct effect on the mechanical 
properties and the β phase stabilisation.  
Ta is considered a biocompatible β stabiliser material (67,76). Furthermore, Ta 
was added as a third alloying element for the TiNb alloys in this study to improve the 
superelasticity and mechanical properties (77). The addition of Ta has an influence in 
reducing the martensitic transformation temperature. It was found that adding a 1% 
of Ta to Ti22Nb alloy could reduce the martensitic start temperature about 30K 
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(59,78). Ti22Nb(0-8at%) were fabricated and studied in order to determine the effect 
of Ta addition (59). In the XRD results for the binary Ti22Nb alloy only a weak β phase 
peak appeared while most of the other peaks corresponding to α” phase. By increasing 
the Ta content in the alloy to 6at%, only strong β peaks appeared. The martensitic start 
temperature Ms decreased from over 400K for TiNb to below 200K for the alloy with 
8at% of Ta as shown in Figure 2-6.  
 
Figure 2-6: Ta content effect on Ms temperature for Ti22Nb(0-8)Ta alloys (59) 
 
2.3 Potential manufacturing processes for the carrier 
Several manufacturing processes and methods of producing Ti alloys were 
surveyed and studied to find the suitable process for manufacturing Ti alloys to act as 
a Ti carrier for a catalyst (i.e. Palladium). The main requirements of the process are: 
I. The process has to be cost-effective  
II. Manufacturing has to be quick  
III. Capable of manufacturing an alloy that has a stiffness value close to bone’s to 
withstand physical load 
IV. The material produced has to be biocompatible (e.g. Titanium) 
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V. Capable of producing β phase titanium alloys to benefit from the superelasticity 
behaviour  
VI. Environmentally Safe 
These requirements are the criteria used to select the optimal manufacturing process 
for the carrier.  
2.3.1 Additive Manufacturing (3DP) 
In the last thirty years, three-dimensional printing (3DP), also called additive 
manufacturing, has been growing in the manufacturing field (79).  It is a technique used 
to manufacture complex component and parts by slicing a solid model into layers and 
then building the part up, layer by layer, by using sintering, deposition or binding, 
depending on the mechanism used for the powder to become a solid.  
1) Sintering. In this process the powder is spread and then sintered or melted 
using an electron beam or a laser as a heat source. 
2) Deposition. The source material, powder or wire, is melted during its deposition 
(80)  
3) Binding. This process requires a “glue” to fuse the powder.  
Sintering and deposition techniques are suitable for metal, ceramics and polymers 
transformations. Binding is only used, so far, for ceramics and polymers. Directed 
energy deposition (DED) is one of the sintering techniques to manufacture metallic 
parts which is performed by feeding of a wire or metal powder to a heat source to melt 
the material at the same time, as shown in Figure 2-7. Each layer of the molten metal 
solidifies on the last layer of the metal as the machine receives the data from a 
computer-aided drawing (CAD) file to build the sliced part. This process can be used 
to fabricate pure metal parts which give it high potential to be used in the aerospace 
and medical manufacturing industries (81). 
An advantage of DED process is that it can be fed different powder elements at the 
same time to produce the desired alloy. By controlling the feeding rate of the powders, 
it can achieve different microstructure and chemical composition of the alloys. On the 
other hand, the final rough surface and low powder efficiency are major disadvantages 
of the DED technique (82-85).  
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Although Titanium alloys have been fabricated using the DED technique (86), heat 
treatment is needed after their fabrication due to the heat hardening phenomena 
during cutting or machining of the alloys because of its poor machinability 
characterisation (87). The high capital cost of elements and hardware (i.e. inert 
atmospheres) used to fabricate Titanium alloys has limited the widespread use of DED 
technique with respect to other materials (88).  
 
Figure 2-7: Schematic showing direct energy deposition (89) 
Another example of sintering technique is powder bed fusion (PBF), which is 
performed by melting selective powders from a powder bed based on the data 
provided from a CAD file (Figure 2-8). The disadvantage of this process is the waste of 
the powder that is not melted and the need of a significant amount of powder to fill the 
working platform. The hardware costs more than other 3DP processes which limit it 
to low-cost materials (89).    
 
Figure 2-8: Schematic showing powder bed fusion technology (89) 
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The low speed of this technique has not allowed it to develop as an economical 
technique in mass production (88). 
After investigating 3DP technologies to fabricate Ti alloys, 3DP was found to be 
economically costly because it needs advanced equipment and skilled operators for 
this work or application. Moreover, the unavailability of equipment and material were 
a challenge for this project to apply this method. These encouraged us to explore other 
manufacturing techniques.   
2.3.2 Metal Injection Moulding (MIM) 
Metal injection moulding (MIM) is a manufacturing process used to overcome the 
issues with conventional techniques for fabricating complex shapes and accuracy of 
part dimensions (90). It is a process that combines plastic moulding and powder 
metallurgy techniques (91). In MIM process, the powder metal mixed with a binder, 
usually polymer or wax, is fed into the mould by injection of the feed. After that, a 
debinding and sintering process is needed to remove the binder and obtain the final 
part as shown in Figure 2-9 (92).  
A major advantage of this process is the flexibility of composition and simplicity 
for the fabrication of complex parts (93).  However, the high cost of designing and 
fabricating a mould in the first place for each part is a major disadvantage of this 
process, which increases the overall manufacturing process cost.  
 
Figure 2-9: Metal Injection Moulding Process (MIM) (91). 
Another economic disadvantage is the need of using fine spherical titanium 
powder. The size of these spherical powder should be less than 45 µm and it must be 
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low-oxygen. These spherical particles can be produced by gas atomisation or by 
plasma wire-based atomisation process (94). Even so, this is an essential reason to 
limit the growth of MIM process in the manufacturing industries because of the high 
cost of the fine low-oxygen spherical powder (91).   
Although interest has grown in the last decade in the MIM process as a promising 
technique to manufacture Ti alloys (95), which stimulated us to investigate the 
features of the process and evaluate the ability to use it for fabricating the catalyst 
carrier, the disadvantages of the process prevent us from achieving the aim of this 
research. 
2.3.3 Powder metallurgy technique (PM) 
Powder metallurgy (PM) techniques are used to fabricate materials and alloys 
directly from powders. It can be used to manufacture different materials such as metals 
and its composites with polymers and even ceramics. PM is considered as one of the 
most effective manufacturing processes due to its low cost compared to the other 
advanced manufacturing processes, the simplicity of the technique and its high 
efficiency (96). 
The PM technique typically consists of three major steps. The first step is mixing 
the powder of different elements as required to design an alloy or by preparing the 
powder by classifying it based on its particle size. The second step is fabricating the 
green body by pressing the powders in a metallic mould at a certain pressure to obtain 
a solid sample. In the third step, the green body is heat treated (i.e. sintered) to a 
certain temperature which makes the particles more connected and more strongly 
linked (97). 
Ti13Nb13Zr alloy was fabricated by Powder metallurgy technique for aerospace 
and material applications. The powders were mixed and cold pressed at 300 MPa and 
then the samples were sintered in a vacuum furnace with a vacuum level of 10-6 Torr 
and with a temperature of 900 to 1500°C dwelling for 1 hour (98). Also, Ti alloys with 
the same alloying elements and space holder were produced for biomedical 
applications. A study to produce TiNbZr alloy was performed by powder metallurgy 
using NH4HCO3 as a space holder. The mixture of powder was cold pressed and 
sintered in a vacuum of 10-5 Torr. The first sintering process was to remove the space 
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holder at 175°C for 2 hours and then the temperature increased to 1200°C for 1 hour 
(99). TiNbSn alloys were also manufactured using Powder metallurgy (100). Also, 
Wang et al. manufactured Ti35NbxSn by powder metallurgy technique. The powders 
were mixed and milled by ball milling machine for 24 hours under argon atmosphere 
and then the mixture was uniaxially cold pressed. The sintering process occurred in a 
10-3 Torr vacuum furnace at 1000°C and under a pressure of 60 MPa during the 
sintering process (101).   
Due to the advantages offered by this technique, which allows the fulfilment of the 
process requirements, it was selected as one of the methods to fabricate the carriers.  
2.3.4 Arc Melting (AM) 
The Arc melting process has been used for many years to manufacture Titanium 
and its alloys. The process is performed under vacuum and an inert gas atmosphere 
(i.e. Argon) which prevents the sample from being oxidised or contaminated in the 
repetitive process of flipping the sample to homogenise its composition through full 
melting. The vacuum atmosphere and the purity of the samples are considered as 
major advantages for the medical industry to fabricate dental casts and medical 
devices (102). Ti and Ti6Al4V were cast by Taira, M. et al. using arc melting method for 
dental purposes (102). Ozaki et al. used an arc melting process to fabricate binary Ti-
V alloys with variable compositions of Ti-(16-50)mass% and Ti-Nb alloys with mass 
weight Ti-(36-52)mass% (73). Furthermore, Ternary alloys were fabricated using the 
same method by adding Sn to the alloys. The process was performed under argon gas 
atmosphere and the ingot was flipped five times. After that, the ingots were cold rolled 
and annealed in a vacuum furnace for 24 hours at 1150°C. The samples were 
encapsulated in a quartz tube and heat treated for 30 minutes at 950°C and then 
quenched in ice water (73). Matsumoto et al. fabricated Ti35Nb4Sn alloy using arc 
melting process. The melting carried out under argon atmosphere to avoid 
contamination and oxidisation in the sample. The melted ingot was annealed for 24 
hours at 1150°C and then it was cold rolled to thickness of 1.4, 2.0 and 3.3 mm (103). 
The reproducibility of the manufactured samples along with the flexibility of the 
process are two advantages that place this technique as a strong contender in the 
selection process for a carrier manufacturing procedure. More than one sample can be 
produced at the same time and different shapes can be cast based on the casting mould 
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used. Furthermore, the purity of the melted material due to the vacuum chamber and 
the inert gas coating during the melting process put the arc melting process in the top 
of the list.   
2.4 Evaluation    
From evaluating these different manufacturing processes to fabricate Ti and Ti 
alloys (Table2-1), powder metallurgy and arc melting process were found to be the 
most feasible methods used to fabricate Ti alloys in this study. Therefore, these two 
processes were used to manufacture the catalyst carrier. They have more flexibility in 
the preparation of the alloys, rapid manufacturing and low volume manufacturing. 
Table 2-1: Evaluation matrix for the carrier manufacturing processes 
Process Cost effective 
Rapid 
production 
Can produce 
Ti and β Ti 
alloys 
Environmentally 
Safe 
 
3DP 
High cost of 
equipment and 
material 
Low build 
rate 
Under 
research Safe 
MIM 
High cost due 
to the need for 
mould for each 
part design 
Not possible 
due to the 
need for 
mould 
fabrication 
and post 
processes 
Unknown 
Some health and 
safety issues 
PM 
Low cost of the 
process 
Possible  
Yes 
safe 
AM 
Low cost of the 
material and 
process 
Possible to 
produce more 
one sample at 
a time. 
Yes 
safe 
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2.5 Potential coating processes 
Several coating processes and methods of coating or joining metals were evaluated 
and studied to find the suitable process for the application of thin palladium film to act 
as a catalyst onto the Ti carrier. The main requirements of the process are: 
i. The palladium coating and the substrate elements should not be alloyed 
together. 
ii. A Minimal mass of palladium should be used. 
iii. The process has to produce highly uniformed coatings. 
iv. The coating must be free from toxic constituents and high purity of the metallic 
surface since metallic Pd0 is required to be the final coating material to undergo 
biochemical reactions. 
v. All materials used in this research have to be biocompatible materials. 
vi. The process is required to be time and cost effective.   
2.6 Powder Metallurgy 
2.6.1 Powder metallurgy 
Powder metallurgy technique was surveyed and explored. The method was 
reviewed and presented in section 2.3.3. The process was chosen to be considered in 
the coating process stage due to its simplicity, cost effectiveness and the availability of 
the equipment and materials.  
2.6.2 Powder metallurgy with space-holder  
Powder metallurgy process is also a technique used to fabricate porous materials. 
The demand for the manufacture of porous materials has increased in the recent years. 
There are several applications for porous materials such as filters, medical implants 
and industrial applications. The manufacturing procedures and parameters of porous 
materials can change the physical properties of the materials, in particular its surface 
area.  
Powder metallurgy techniques with a space holder is a very effective method to 
produce high surface area materials. The process includes mixing the base material 
with the space holder, compressing, calcinating and sintering processes.  The surface 
area can be easily controlled by adjusting the porosity percentage and the space holder 
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material particle size. Increasing the roughness of the surface increases the surface 
area. There are different space holder materials that have been used to produce porous 
materials such as magnesium (104), ammonium carbonate (105), carbamide (106), 
urea (107) and sodium chloride (108). 
A study by Dezfuli et al. used urea as a space holder to improve the surface 
roughness of Ti for medical applications. Ti powder was mixed with urea with particle 
size range from 300-600 µm. The space holder was removed from the sample during 
the sintering process of the sample at a temperature range 400°C to 1000°C in a 
vacuum chamber. The SEM results exhibited a higher surface roughness and the study 
concluded that the surface roughness could be improved by employing the space 
holder technique (109).    
2.6.3 Powder metallurgy with negative mould  
To apply a layer of palladium using a negative mould, which was designed and 
fabricated in-house was a way to increase the surface area of the layer by increasing 
the macro roughness of the outer surface. A stainless-steel mould with internal 
diameter of 10 mm was fabricated with a plunger with a negative shape. Two different 
plunger designs were realised, one with strips with a groove of 1 mm and 1.5 mm 
distance between the strips, and the other one with crossed lines with the same size of 
the grooves and the same distance between the crossed lines as shown in Figure 2-10. 
These two shapes were suggested with the purpose of increasing the surface area.  
 
Figure 2-10: Negative mould plungers  
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However, due to the tight tolerances and the high pressure applied to the plunger 
to lower it and form the green body, a large amount of the powder got stuck on the 
plunger and was lost. Furthermore, in the process of removing the plunger from the 
mould most of the sample broke which is not a good feature for mass production. 
Therefore, this manufacturing process was discarded.  
2.6.4 Soldering and brazing 
Soldering and brazing processes are considered as joining methods for solid 
materials (110). The process entails the use of a solder that can be melted and form a 
bond between it and the base metal. Different solders can be used based on the process 
requirements and the surface condition of the base metal. It can be a solid wire, a film 
or a paste solder (111). The Soldering process is being used widely to join electronic 
and electric devices components. The lead-base solders ban came to overcome the 
toxicity and health issues accompanied the presence of lead in solders (112). In July 
2006, lead-free solders started to be used to replace the lead-base solders in the 
electronics manufacturing in submission to The European Union’s Waste from 
Electrical and Electronic Equipment (EU-WEE) orders (113).  
The need for lead-free solders introduced different solders such as Au-Sn, Au-Ge, 
Zn-Al, Zn-Sn, Bi-Ag and Sn-Sb based alloys (114).  However, Au and Bi-based alloys 
solders have a major disadvantage which is the high cost of the material (115). 
Biocompatible solders were used to join parts of implanted electronic device. Sn-Ag 
solder was used successfully to join a silicon chip with a thickness of 16 to 25 µm with 
5µm tapes.  
Mass soldering methods are used to join parts because of their high productivity. 
However, mass soldering methods are not applicable for precise applications. 
Therefore, selective soldering methods are available to overcome this issue. Selective 
soldering methods depend on major factors such as controlling the temperature of the 
process and the amount of solder deposited. Hence, to increase productivity and 
reduce the processing time, excessive temperatures are applied. The temperature 
ranges between 320°C to 400°C depending on the type of solder used. Different heat 
sources can be used such as gas, solid body, radiation, electric current and solder. Also, 
different solder types can be used with these hot sources such as wire, paste and liquid 
form. The challenges with using a soldering wire are controlling the amount deposited 
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and using paste requires the solder to be heated in the place of the joint while using a 
liquid solder it needs high temperature and it could be exposed to other areas (116). 
To the best of the author’s knowledge, no successful soldering process involving Pd 
onto Ti has been reported.  
2.6.5 Welding 
Welding is a joining process used to join metal together by applying heat and 
causing fusion between the joined materials. It may use filler or not as a medium to 
join different materials. However, in general, the fusion welding processes cannot be 
used to join materials with different melting temperatures but there is an exception 
for a combination of some materials and by using specific welding processes. Fusion 
welding has some challenges to weld dissimilar metals. Therefore, different welding 
processes are available to overcome these limitations such as pressure welding, 
friction welding resistance and diffusion welding (117). Diffusion welding can be used 
to join small parts of dissimilar metals. Yet, it is considered as low rate deposition 
process and time-consuming. It can be used for precise parts to be joined and 
fabricated. However, the time-consuming for the process increases the manufacturing 
cost.   
Titanium and Aluminium were successfully welded by diffusion welding. The 
Titanium and Aluminium can easily form a film of oxide due to the chemistry activity 
of the material which can prevent the diffusion occurred. Therefore, further 
preparation of the surfaces is required to remove the oxide film. The welding process 
was performed in a vacuum chamber with a temperature of 640°C and held for 90 
minutes under a pressure of 24 MPa (118). Also, Titanium was welded to different 
materials such as copper (119), stainless steel using Ni as interlayer (120) and carbon 
steel using silver as interlayer (121). 
It has not been possible to find in the open literature information about any 
established welding method to directly bond titanium to palladium or  by the aid of 
different material as interlayer. Nevertheless, it remains questionable in terms of how 
the welding process could help retain the unalloyed state of metallic palladium. 
        
                            Literature Review 
28 
 
2.7 Thin film deposition 
Electroplating, electroless-plating and other chemical vapour deposition methods 
were explored, studied and evaluated to be used in this research. 
2.7.1 Chemical vapour deposition (CVD) 
Chemical vapour deposition (CVD) method is a deposition method used to deposit 
a solid material onto a heated substrate by chemical reaction on the vapour phase 
(122). Deposition of noble materials such as gold, palladium, platinum and rhodium 
has several applications in protection and in the catalysis industry (123-126). 
CVD has several advantages such as the high rate of deposition and the application 
of thick coating which can achieve squared centimetres. Also, coating rough and porous 
surfaces are possible with CVD. However, CVD has major disadvantages such as the 
high temperature of the process which is between 300 to 1600°C (127,128). In 
addition, the chemical hazards from the chemical reactions occurred in the process and 
the toxicity of chemical vapour (129,130). In this project, the substrates are thermally 
sensitive and β phase will not be stable at this high temperature. Therefore, this 
method was discarded. 
2.7.2 Electroplating  
The electroplating process occurs by immersing a metal into a solution bath that 
contains ions of the plating metal. An exchange occurs between the solution ions and 
the metal ions, which could occur at the same time or one faster than the other (131). 
Tang & Zuo (132) deposited thin palladium film on a 316L stainless steel substrate 
by electroplating and electroless plating processes. The electroplating bath contained 
PdCl2 : 15g/L, NH3.H2O: 15m/L, NH4Cl: 50g/L, (NH4)2PO4: 50 g/L. While the electroless 
plating bath was PdCl2: 2 g/L, NH3 H2O (28%): 150 ml/L, HCl: 4 ml/L, NH4Cl: 27 g/L, 
NaH2PO2: 12 g/L, temperature: 50 °C, time: 30–60 min. A palladium coating film of 2 
µm was deposited on the substrate in 2 minutes. The surface coating was smooth and 
uniform (132). However, the deposition rate was not controllable, and the deposited 
coating film was too thick.   
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2.7.3 Electroless Plating  
The electroless plating process consists of three major steps: surface preparation 
and cleaning, activation of the surface and coating deposition. In the first step, the 
surface has to be cleaned using a dilute acid, alcohol and rinsing with distilled water.  
After that, the surface is activated using a tin chloride sensitiser. In the case of 
palladium, an activation bath of palladium is used to deposit palladium clusters on the 
surface of the substrate. However, Sn tends to deposit on the surface of the substrate 
with a notable amount from the tin chloride sensitising agent (133,134). The Palladium 
cluster deposited on the surface works as a reaction catalyst for the plating process. 
The plating bath for palladium normally contains sequestering agent such as Na2EDTA 
and palladium-amine complex and the coating deposition obtained by chemical 
reduction of Palladium ions using a reduction agent (133,135-137). After the 
deposition process, the substrate is annealed in a vacuum furnace to ensure 
homogenisation of the coating.  
A major disadvantage of the electroless plating for palladium is the impurity of the 
coating film due to the presence of carbon or tin on the surface. It has been reported 
that palladium electroless plating coating contains up to 6.5 wt% of carbon and also 
contains other elements from the plating bath (138). Furthermore, the deposition rate 
cannot be controlled due to several factors such as temperature of the deposition 
process, substrate surface topography and concentration of plating bath (139). 
Therefore, high deposition rates can cause defects, voids and non-uniformed thickness 
in the coating film. Several researchers reported deposition of palladium film with a 
different thickness between 1µm (140) and 33µm (141). These issues deemed this 
technique invalid for this study’s application. 
2.7.4 Magnetron Sputtering Deposition (SP) 
Magnetron sputtering Deposition (SP) was chosen to apply the palladium coating 
film because it is one of the physical vapour deposition methods that can produce a 
high-quality thin coating. Reducing the thickness of the coating would reduce the use 
of raw material deposited on the substrate. The process is widely used to produce hard, 
thin and well-adhered coating films. One of the advantages of this process is the ability 
to deposit continuous and uniformed film over a rough surface (142).  
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The SP process is conducted in a vacuum chamber as shown in Figure 2-11 to 
reduce impurity and ensure a clean coating deposition. The palladium target is 
installed above the substrate inside the vacuum chamber. Then, the chamber is filled 
with a plasma gas, usually Argon gas, and the plasma gas will remove palladium atoms 
from the target. The electrons will travel freely because of the electric potential 
between the palladium target and the titanium substrate. The magnetic field which is 
generated from the magnetron will keep the electrons near the target.  Then, the argon 
gas hits the electrons creating positive charge ions. Plasma light then will be produced 
due to the recombination between some of the ions with the electrons. The free ions 
instead will travel towards the palladium target and remove their surface atoms. These 
atoms will then accelerate toward the substrate to collide and create a thin coating. 
The coating thickness can be controlled either by the time of sputtering or the 
thickness gauge most of the coating systems are equipped with (135). 
Pd-Ag and Pd-Cu targets have been used to deposit thin film coatings using the 
magnetron sputtering method (143,144). Thin coatings of 100-500 nm have been 
successfully deposited using a Pd-Ag target by sputtering as reported by Xomeritakis 
& Lin (145).  
 
Figure 2-11: Magnetron sputtering process (142)  
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2.7.5 Pulsed Laser Deposition (PLD) 
Pulsed laser deposition (PLD) is one of the physical depositions which do not 
include any chemical reaction in the process. PLD can be used to deposit different 
metallic materials by changing the target to the desired material. The PLD process is 
performed in a vacuum chamber to avoid any oxidation of the material due to the heat 
involved in this process. A focused ion beam is used to remove atoms from the target 
and create a plasma perpendicular to the surface. The removed atoms from the target 
material deposit on the substrate to form a thin coating film (146) as shown in Figure 
2-12. 
Two Palladium films were successfully deposited by Pulsed laser deposition with 
a film of Magnesium in between by Bouhtiyya & Roue (147). The thickness of the 
palladium films was 15 nm and the thickness of the magnesium was 170 nm. The films 
were deposited on Ni substrate. Work by Kumar et al. reported 50-200 nm of thin 
palladium films deposited on a quartz substrate. The XRD results obtained from these 
films exhibited the presence of Palladium in its cubic metallic state (148).  
Material droplets and discontinuities on the coating surface are considered as one 
of the major disadvantages for pulsed laser deposition. It makes it difficult to deposit 
smooth, uniformed and high-quality coating (149). However, the presence of droplets 
can be an advantage if a rough surface coating is required.       
 
Figure 2-12: Schematic of Pulsed Laser Deposition process (modified) (146)  
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2.7.6 Supersonic Cluster Beam Deposition (SCBD) 
Supersonic cluster beam deposition (SCBD) is a technique used to grow a 
nanostructured film by collecting clusters onto a substrate. The deposition process 
occurs in a vacuum deposition chamber. The nanoparticles are generated from the 
source and then sent to the deposition chamber through an expansion of the gas jet 
(150). The nanoparticles are deposited on the substrate to form a thin film as shown 
in Figure 2-13.  The nanostructured thin film produced on the substrate can keep the 
original structure of the cluster deposited (151,152).  
 
Figure 2-13: Supersonic cluster beam deposition process (150) 
Carbon films have been produced by supersonic cluster beam deposition process 
with a thickness of 20 nm by Milani and co-workers (153). Also, palladium clusters 
were deposited on poly (methyl methacrylate) surface. A pure palladium target rod 
was used to generate palladium cluster by pulsed microplasma cluster source and 
delivered by helium jet gas. The thickness of the palladium nanoparticles deposited on 
the substrate was 60 nm as measured from the cross-section of the substrate (154).  
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2.8 The prodrug concept 
The concept of a prodrug can be explained as the changes in the chemical 
properties of a drug to utilise the usefulness of the drug unlimitedly. For example, if 
the drug is not able to overcome a barrier due to its physicochemical properties, the 
chemical properties can be changed by attaching an activating agent to create a new 
chemical product that has the ability to cross the barriers (155). The concept of the 
prodrug is illustrated in Figure 2-14.   
 
Figure 2-14: Prodrug concept (15) 
Several drugs developed and manufactured in the late nineteenth century are in 
fact prodrugs. From example aspirin is a prodrug of salicylic acid; also, hexamine is a 
prodrug of formaldehyde (155).  
2.9 Targeted anticancer therapies    
Targeted anticancer therapies by using an implanted device is not a new concept 
(156). In the last decades, targeted anticancer therapies helped to cure many cancer 
tumours such as lung, renal and breast cancer (157). Many ideas and devices were 
introduced and used as anticancer treatment (158). The main objective of using this 
kind of method is to reduce the side effects of the chemotherapy (159). One of the ideas 
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used to overcome this issue is the Gliadel™ wafer (160-162). These wafers were used 
clinically to treat the brain tumours (163). However, these wafers are limited by their 
cargo capacity. If the drug content being released exhausts, these wafers are useless. 
To overcome this issue, the fabrication of catalyst-carrier devices has been recently 
proposed. 
Another major issue in anticancer drugs is the toxicity to the host (164). Using a 
biocompatible material can reduce the toxicity and the side effects of the drugs. It is 
important that the final product used to activate the drug should be nontoxic and 
biocompatible. Furthermore, metals are used as well in the living cells systems to 
activate fluorogenic probes. These processes are called biorthogonal organometallic 
reactions (BOOM) and are done by using metals such as ruthenium, copper and 
palladium. Palladium metal (Pd0) has worked as a dual catalyst and delivery system 
that has the ability to enter the cells without toxicity. Pd0 shows the safest toxicity 
profile amongst all other palladium species due to its biological inertness. Pd0 is widely 
used in metal alloys for dental applications. Implants using Pd0 as catalysis can activate 
the prodrug in a spatially controlled manner. Palladium-activated prodrugs depend on 
the catalytic properties of the transition metal. The prodrug will remain inactive in the 
absence of the palladium source in the system (17,165).  
The advantage of using a metal-functionalized device to kill the cancer cells is that 
the palladium-labile prodrug will be activated only within the cancerous tissues. 
Therefore, that would help in increasing the concentration of the drug applied locally 
while decreasing the drug side effects in the healthy organs and tissues elsewhere. 
Furthermore, it is an ideal technique to treat advanced cancer cells that cannot be 
treated by surgical resection.  
From literature, Ti and its alloys have been considered as one of the most 
biocompatible materials and used in different medical applications. However, some  
alloying elements  were noted as cytotoxic such as Ni, Al and V which used to fabricate 
TiNi and Ti6Al4V alloys. Therefore, TiNb alloys came to overcome this issue. 
Furthermore, adding a third alloying element improved the mechanical properties of 
the alloy. TiNbSn alloys showed that the Young's modulus can be reduced to 40 GPa by 
controlling the amount of the alloying elements added. Thus, in this study TiNbSn alloy 
was chosen to be used as the main alloy for the carrier. Also, adding Nb and Sn to the 
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alloy have been suggested to demonstrate β phase microstructure which has a low 
stiffness value and excellent mechanical properties that can fulfill the requirements.  
On the other hand, adding Ta to the alloy improves the mechanical properties and 
reduces the alloy stiffness. Moreover, adding Ta to TiNb alloy reduces the 
transformation temperature about 30K for each 1%wt of Ta, which further stabilises 
the β phase close to room temperature. Hence, TiNbTa alloy was designed and 
manufacture in this research. 
Different alloy manufacturing methods were studied to identify the optimal 
manufacturing method. From the literature review, powder metallurgy technique and 
arc melting process were found to be the most suitable methods based on the 
evaluation criteria and the list of the requirements for this study. Many researches and 
studies used arc melting method to benefit from the rapid cooling process during the 
manufacturing process. Other methods such as additive manufacturing and metal 
injection moulding were found to be unavailable from this research due to several 
reasons. One of the reasons that the manufacturing of Ti alloys using additive 
manufacturing method still under research. Furthermore, the total cost of the material 
and equipment used is high compared to other manufacturing processes.  
Coating methods were explored to know the suitable method for this study. List of 
requirements was set to choose the optimal coating method. From the literature, 
physical vapour deposition methods were found to be the most suitable methods to 
apply the catalyst material on the carrier. Physical vapour deposition methods 
overcome the issue of the amount of material being deposited by other deposition 
methods. Chemical vapour deposition method was not a suitable method to be used in 
this application due to the high temperature involved in the process and the chemical 
changes in the material deposited. While, welding process and soldering and brazing 
method were not possible to find in the literature studies joined Ti to Pd. 
In conclusion, TiNbSn and TiNbTa alloys found to be the most suitable alloys that can 
be tailored and adjusted to fulfil the carrier requirements in this study. Although, 
powder metallurgy technique and arc melting method are the most cost and time 
effective methods. Physical vapour deposition methods are considered to be the 
method that cover all the requirements for this research.
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3 Catalyst Carrier 
3.1 Introduction 
This chapter describes in detail the techniques and methods that were used in this 
research to fabricate the catalyst carrier and the characterisation methods and 
techniques used to test the different catalyst carriers manufactured. Different 
manufacturing methods were explored: 1) the carrier was manufactured using powder 
metallurgy techniques and a sintering process; 2) the carrier was fabricated using an 
arc melting process. Four different Titanium (Ti) alloys, an additional heat treatment 
process followed to obtain the stabilisation of the desired crystal structure at room 
temperature. 
3.2 Manufacturing process of the carrier  
In the first instance the carriers were made of pure Ti and lately fabricated in 
titanium alloys with the intention to tailor their mechanical properties, reduce their 
stiffness to a value close to bone’s and let them exhibit a superelastic behaviour taking 
advantage of β-Ti phase crystals when sustaining physical loads.   
3.3  Pure Titanium carrier 
3.3.1 Materials and methods  
Titanium powder (-325 mesh, particle size 0.044 mm, 99.5% (metal basis) packed 
under Argon, from Alfa Aesar Company,UK) was used as raw material. Due to the 
flammable nature of the titanium particles safety precautions were taken into 
consideration. 
3.3.2 Powder pressing  
To form a green body sample of 16 mm diameter and 1 mm height, the powder 
was poured into a stainless-steel mould using a plastic funnel and then the central 
plunger was inserted carefully to avoid any losses of the powder due to the evacuation 
of air due to the installation of the pressing plunger. A hydraulic pressing machine 
(Press 40 Specac, Atlas,UK) was used to compress the powder and to fabricate the 
green body of the substrate as shown in Figure 3-1.  
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Figure 3-1:  a) Stainless steel mould, b) pressing machine, c) sintered sample                          
3.3.3 Sintering process 
The sintering process was performed in a ceramic tube furnace (Lenton LTF 
1400°C, USA). The carriers were placed in alumina boats and inserted in the furnace 
tube. The furnace was at a vacuum level of 10-5 mbar to avoid any oxidation during the 
process using a vacuum pump (Pfeiffer Vacuum Hi Cube 80, Germany) as shown in 
Figure 3-2.  
 
Figure 3-2: Tube ceramic furnace and vacuum pump connected to the furnace 
 
 
The catalyst carriers were heated up to 1200℃ and held for 2 hours. The 
temperature increment rate of the furnace was set to be 5℃ per minute from room 
temperature until 600℃ and then 3℃ per minute until the temperature reached 
1200℃. When the required temperature was obtained, the furnace held the 
temperature for 2 hours. After that, the furnace cooled down at the same rate until it 
reached room temperature as shown in Figure 3-2 (inset).  
a b c 
                            Catalyst Carrier 
38 
 
More details of the steps and the procedure used to manufacture the substrate are 
presented in appendix 1. 
3.4 Titanium alloys carrier 
3.4.1 Designing the alloys 
Different alloy compositions were selected to manufacture the carrier with the aim 
of lowering of stiffness and a superelastic behaviour. These alloys were designed based 
on the literature review and alloy designing methods. The DV-Xα cluster is a method 
used to design alloys based on their 𝐵𝑜̅̅̅̅  and 𝑀𝑑̅̅̅̅̅ energy links. It defines the relationship 
between the electronic parameters of the alloying elements and the stability of the 
phase, i.e. between the orbital energy level (𝑀𝑑̅̅̅̅̅) and the bond strength between 
alloying elements (𝐵𝑜̅̅̅̅ ). 
The composition of the alloys was chosen to achieve β phase alloys and β+α alloys 
with the help of β phase stabiliser elements.  
3.4.1.1 Alloying Elements 
Three different alloying elements were chosen due to their biocompatibility and 
for having excellent β phase stabilising properties. For that reason, Niobium (Nb), 
Tantalum (Ta) and Tin (Sn) were used to be the alloying elements. Nb was chosen to 
be the main alloying element because of its high β stabilising effect on Ti alloys. It has 
been reported in the literature that Sn does not act as a β phase stabiliser. However, 
when Sn is added to Nb it does stabilise the β phase in the Titanium based alloys. Hence, 
Sn does not affect the 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ parameters as much as the amount of Nb does.  
The alloys were designed to contain 30, 35 and 37 %wt of Nb and 4 and 6 %wt of 
Sn. One alloy was designed to contain 14%wt of Ta. Based on the 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ diagram 
(Figure 3-3), these alloys were expected to have different crystallographic phases as 
shown in Table 3-1. 
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Table 3-1: Alloys composition and Expected phases 
Alloy composition (%wt) Expected phase 
Ti30Nb4Sn Beta+alpha 
Ti35Nb4Sn Beta 
Ti37Nb6Sn Beta 
Ti35Nb14Ta Beta 
3.4.1.2 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ Diagram 
The electronic parameters for alloying elements used in this research to design the 
alloys are shown in Table 3-2. 
Table 3-2: The electronic parameters for alloying elements 
Element 𝐵𝑜̅̅̅̅  𝑀𝑑̅̅̅̅̅ 
Titanium (Ti) 2.790 2.447 
Niobium (Nb) 3.099 2.424 
Tantalum (Ta) 3.144 2.531 
Tin (Sn) 2.383 2.100 
The parameters of the selected alloys can be calculated using the following 
equations: 
𝐵𝑜 = ∑ 𝑋𝑖(𝐵𝑜)𝑖         3.1  
𝑀𝑑 = ∑ 𝑋𝑖(𝑀𝑑)𝑖         3.2 
Where 𝑋𝑖 is the atomic fraction of the alloy elements and 𝐵𝑜̅̅̅̅  and 𝑀𝑑̅̅̅̅̅ are the 
electronic parameters of each element.   
The calculated values are shown in the table below: 
Table 3-3: 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ parameters for the alloys 
alloys Composition (%Wt) Composition (%at) 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ 
Parameters  
Ti Nb Ta Sn Ti Nb Ta Sn 𝐵𝑜̅̅̅̅  𝑀𝑑̅̅̅̅̅ 
Ti30Nb4Sn 66 30 0 4 79.45 18.61 0 1.94 2.840 2.436 
Ti35Nb4Sn 61 35 0 4 77.06 21.05 0 1.88 2.848 2.435 
Ti37Nb6Sn 57 37 0 6 72.63 24.29 0 3.08 2.853 2.431 
Ti35Nb14Ta 51 35 14 0 70.12 24.80 5.09 0 2.884 2.445 
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The designed alloys were plotted in the 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ diagram and are shown in Figure 
3-3 below. These alloys were selected based on the Bo-Md position. Initially 
Ti30Nb4Sn, Ti35Nb6Sn and Ti37Nb6Sn alloys compositions were chosen to have the 
values close to the Ma=RT line on the Bo-Md diagram. This position was chosen due to 
similarly positioned alloys in literature having been found to possess superelastic 
effects, an important requirement for this study. The slight compositions differences 
of these alloys were used to investigate the effect of the alloying elements in the 
superelastic effects. Alloy Ti35Nb14Ta was chosen as literature suggested a 
composition within this area contained a lower stiffness value as shown in the diagram.   
 
Figure 3-3: 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ diagram as in (166) modified to display the Ti alloys from this 
work 
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3.4.2 Manufacturing the designed alloys  
3.4.2.1 Arc Melting 
An arc melting process machine (MAM1, Edmund Buhler GmbH, Germany), as 
shown in Figure 3-4, was used to manufacture the Ti alloy carriers. The green bodies 
were fabricated using the same pressing procedure as explained in 3.3.2. The weight 
of the titanium powder used to fabricate the green body of the catalyst carrier was 7 
grams to be able to cast a cylindrical bar with a length slightly more 20mm and a 
diameter of 8 mm.  
 
Figure 3-4: a) Arc melting machine, b) Green body for arc melting 
 
 
 
The melting process was executed inside a chamber in argon atmosphere. The 
chamber was flushed with argon and vacuum five times to ensure the chamber did not 
have any contaminating oxygen. 
After the flushing steps, the green body was melted to make an ingot of diameter 
around 16 mm as shown in Figure 3-5 a. The ingot was re-melted and flipped six times 
to ensure the powder was totally melted and the ingot homogenised. Then, the ingot 
was left to cool down for 7 minutes by the water-cooling system connected to the 
melting copper stage. It was then removed from the chamber and a casting stage was 
attached to the machine as shown in Figure 3-5 b. The same flushing procedure was 
repeated.    
More details of the steps and the procedure used to manufacture the substrate are 
presented in appendix 2. 
a b 
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The ingot squeezed cast into a 20 mm long, 8 mm diameter sample. The cast 
sample is illustrated in Figure 3-5 c.  
 
Figure 3-5: a) Titanium ingot, b) casting attachments for arc melting machine, c) 
cast sample 
3.4.2.2 Production of the bulk alloys 
Titanium (Ti) powder (-325 mesh, particle size 0.044 mm, 99.5% purity, packed 
under Argon, a density of 4.506 g/cc, from Alfa Aesar Company,UK) was used as the 
main element for the alloy. Niobium (Nb) (powder purity ≥ 99.8%, a density of 8.57 
g/cc, from Sigma-Aldrich, UK), Tin (Sn) powder (particle size ≤45 µm, purity 99.9%, a 
density of 7.31 g/cc, from Alfa Aesar, UK) and Tantalum (Ta) powder (-325 mesh, 
particle size 0.044 mm, 99.9% purity, from Alfa Aesar Company,UK) were used as 
alloying elements.  
The four alloys and a pure titanium sample were fabricated by arc melting process 
and were cast to create a cylindrical bar with an 8 mm diameter and > 20 mm length 
as shown in Figure 3-6. 
 
Figure 3-6: Cast sample 
a b c 
                            Catalyst Carrier 
43 
 
The alloy cylinders were cut to obtain flat surfaces on both sides to be able to 
conduct mechanical testing. The cut pieces from the bars were used for further tests 
such as XRD, DSC and SEM/EDS.  
The cast samples were encapsulated in vacuum quartz tubes as shown in Figure 
3-7 and heat treated. The quartz tubes were used to prevent the samples from 
oxidisation during the heat treatment process.  
 
Figure 3-7: Encapsulated samples  
The temperature for heat treatment was chosen to be 1200 ˚C and held for 24 
hours for the alloys to investigate the effect of the heat treatment on the 
transformation temperature.  
A ceramic tube furnace was used to heat-treat the alloys. It was set vertically as 
shown in Figure 3-8 to be able to hang the quartz tubes and perform quenching 
process. The furnace reached 1200℃ before inserting the quartz tube. When the 
desired temperature was obtained, the quartz tube was hung using thin nickel wire. 
The nickel wire was used because it can withstand the high temperature and it can be 
cut easily. 
A stand and clamp were used to attach the wire and adjust its length so that the 
quartz tube was located in the middle of the furnace. A ceramic insulation plug was 
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used to close the upper opening of the ceramic tube and keep the heat in, reducing the 
air circulation which may have affected the furnace temperature and cooled it down. 
After the set time, the wire was cut, and the samples fell freely into an iced water 
bucket. The quartz was cracked immediately to be cooled rapidly. After that, the 
carriers were ground to remove the oxidisation layer and cleaned before they were 
taken to further preparation and tests. 
 
Figure 3-8: A vertical set up of the ceramic furnace 
3.4.3 Preparation of the substrates  
After the casting process, the cast material was taken out from the casting tube and 
cut to the required thickness using a slow speed saw as shown in Figure 3-9(a).  Pieces 
of 10 mm diameter and thickness of approximately 3 mm as shown in Figure 3-9(b) 
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were obtained and then polished and prepared for the next stage, the coating 
processes.   
 
Figure 3-9: a) Slow speed saw, b) cast substrate after cutting 
3.4.4 Preparation of the samples for characterisation 
After cutting the cast alloys, each end of the cast alloy cylinder was levelled. A small 
part from the heat-treated sample was prepared for the characterisation tests, while 
the middle part of the cast alloy cylinder was polished and cleaned manually for 
mechanical test. 
The samples were cold mounted using a mounting resin (SpeciFix-20 resin and 
SpeciFIx curing agent) purchased from Struers. The resin and the curing agent were 
mixed in a 5:1 ratio respectively. The samples were placed in rubber moulds as shown 
in Figure 3-10. The mounting mixture was poured on the samples and left for 8 hours 
to cure.  
a b 
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Figure 3-10: a) Rubber mould b) Mounted sample  
Cold mounting was chosen to avoid applying any heat onto the alloys. The 
transformation temperature of these alloys could be below the temperature required 
for the normal mounting process. The mounted samples were removed from the 
moulds by applying a mould release spray. After that, the mounted samples were 
cleaned with acetone and distilled water before polishing them.  
3.4.5 Polishing the samples  
The catalyst carriers prepared by either powder metallurgy technique or arc 
melting process were polished to have smooth and flat surfaces. An automatic 
polishing machine (EcoMet250+AutoMet250, Buehler, USA), as shown in Figure 3-11, 
was used to polish the carriers.  
 
Figure 3-11: Polishing machine 
a b 
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A recommended procedure from the polishing machine manufacturer for titanium 
and titanium alloys was followed. The carriers were polished on silicon polishing 
papers with different grit sizes starting from 320 grit to 600 grit to ensure the surface 
is smooth and level. After that, the carriers were polished using a diamond suspension 
liquid on a cloth material with texture surface of 9 µm, 6 µm and 1 µm respectively, to 
make the surface very smooth and ready for the deposition process. However, a slight 
modification to the recommended procedure was applied to obtain better results. 
Table 3-4 exhibits the procedure used to polish the carriers.   
Table 3-4: Polishing procedure. 
Step Equipment r.p.m Direction Force (N) Time 
2 steps  
Grinding with 
water 
360 grit SiC 240 Contra 25 
 
Until plane 
600 grit SiC Comp. 2 minutes 
3 steps 
polishing 
without water 
9 µm diamond 
suspension  
120 Comp. 25 10 minutes 
6 µm diamond 
suspension 
1 µm diamond 
suspension 
Replenish with polishing spray per 3 min to ensure sufficient supply of polishing 
medium  
2 steps 
polishing 
without water 
MasterPrep 
(0.05µm 
alumina) 
120 Comp. 25 10 minutes 
MasterMet2 
(0.02µm 
amorphous 
colloidal silica) 
Replenish with polishing spray per 3 min to ensure sufficient supply of polishing 
medium 
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3.4.6 Etching the samples for metallurgical characterisation  
After the polishing process, the carriers had to be etched to reveal its 
microstructure and remove the top layer which could contain internal stresses 
occurred in the polishing process. Kroll’s reagent (92% distilled water, 6% Nitric acid 
and 2% Hydrofluoric acid), which is a recommended etchant for Ti and Ti alloys, was 
used. The carriers were swabbed for two minutes and checked under the optical 
microscope and SEM.  
3.4.7 Characterisation and analytical techniques were used 
The carriers were tested before and after the heat treatment process to explore 
the transformation temperature, phase change and their microstructure. Different 
characterisation methods and techniques were used in this research to investigate the 
properties of the alloys. Differential Scanning Calorimetry (DSC) was implemented to 
detect the transformation temperature for the alloy. Scanning electron microscopy 
(SEM) with energy dispersive spectroscopy (EDS) were used to determine the 
microstructure of the alloys and detect the chemical elemental composition of the 
alloys. X-ray diffraction (XRD) was executed to investigate the crystal phases of the 
alloys. Furthermore, compression (including static and cyclic) and hardness tests were 
completed to determine the mechanical properties of the alloys.   
3.4.7.1 Differential Scanning Calorimetry (DSC) 
Differential scanning calorimetry (DSC) test was conducted using a temperature 
range from -20 °C to 250 °C and with a heating rate of 10 °C /min. Results from DSC 
analysis for the four Ti alloys are presented in this section. DSC analysis for the alloys 
before being heat treated and after the heat treatment are illustrated to investigate the 
effects of the heat treatment process on the transformation temperature of the alloys. 
DSC results for Ti30Nb4Sn did not exhibit an obvious peak within the temperature 
range used for the test (i.e. -20 to 250°C). Although a peak appears around 78°C before 
the heat treatment, it disappeared after the alloy being heat treated with a small peak 
at 56°C being detected as shown in Figure 3-13. The peak at 78°C is linked to the 
transformation from α” to β phase. The same transformation moved to a lower 
temperature due to the heat treatment and quenching process as shown in Figure 3-13.  
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Figure 3-12: DSC result for Ti30Nb4Sn before heat treatment 
 
Figure 3-13: DSC result for Ti30Nb4Sn after heat treatment 
For Ti35Nb4Sn, the transformation temperature dropped from 123°C before the 
heat treatment to 48°C after the heat treatment as shown in Figure 3-14 and Figure 
3-15. The transformation in this alloy is linked to  a phase transformation from α” to β 
phase with a similar drop after heat treatment compared with the Ti30Nb4Sn alloy. 
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Figure 3-14: DSC result for Ti35Nb4Sn before heat treatment 
 
Figure 3-15: DSC result for Ti35Nb4Sn after heat treatment 
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For Ti37Nb6Sn alloy, a martensitic peak appeared at 43°C before the heat 
treatment process for the alloy as shown in Figure 3-16, while a small peak appears 
around 58°C after the heat treatment as shown in Figure 3-17.  This is likely due to the 
difference in the cooling rate after casting between this alloy and the previous alloys.  
 
Figure 3-16: DSC result for Ti37Nb6Sn before heat treatment 
 
Figure 3-17: DSC result for Ti37Nb6Sn after heat treatment 
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A small peak appears around 30°C for Ti35Nb14Ta alloy and this peak 
disappeared after the heat treatment process, as shown in Figure 3-18 and Figure 3-19. 
This peak is linked to the transformation of α” to β. The lower temperature likely 
results from the increased β stabilisation compared with the previous alloy. This 
increased β stabilisation is the results of the addition of Ta to the alloy. The absence of 
the peak after the heat treatment is probably the result of the lower α” fraction in the 
alloy after quenching.  
 
Figure 3-18: DSC result for Ti35Nb14Ta before heat treatment 
 
Figure 3-19: DSC result for Ti35Nb14Ta after heat treatment  
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3.4.7.2 Microstructure of the alloys 
Microscope images for the alloys were taken to find the microstructure of the alloy 
crystals before and after heat treatment. A Primotech microscope (Zeiss Primotech 
Materials Microscope, USA), as shown in Figure 3-20, was used. The microscope was 
equipped with a digital camera to capture the images. The microscope was connected 
to an iPad with the Matscope iPad Application to process and analyse the images.  The 
samples were etched before analysing to be able to see the microstructure of the alloy. 
      
Figure 3-20: Optical microscope and sample setting 
Images from the optical microscope showed dendritic arms formations on the top 
of the samples. They occurred due to the rapid cooling during the arc melting process. 
However, the dendritic disappeared after the heat-treatment processes for the 
samples. The images after the heat treatment exhibited clear β phase microstructure 
for the alloys Ti35Nb4Sn, Ti37Nb6Sn and Ti35Nb14Ta. While Ti30Nb4Sn showed β+α” 
microstructure as shown in Table 3-5. 
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The images obtained from the microscope are presented in Table 3-5.  
Table 3-5: Compilation of microscope images obtained from the alloys before and 
after heat-treatment (scale bar 200µm) 
Alloy 
 
Before Heat treatment After Heat treatment 
T
i3
0
N
b
4
Sn
 
  
T
i3
5
N
b
4
Sn
 
  
T
i3
7
N
b
6
Sn
 
  
T
i3
5
N
b
1
4
T
a 
  
 
                            Catalyst Carrier 
55 
 
3.4.7.3 Scanning electron microscopy (SEM) with energy dispersive spectroscopy 
(EDS) 
SEM/EDS tests were conducted with a Field Emission electron microscope model 
JSM-7800F as shown in Figure 3-21 (a). The microscope was equipped with a 
computer and software, as shown in Figure 3-21 (b), to analyse the results and images 
obtained from the microscope. It was used to determine the microstructure of the 
alloys and detect the chemical elemental composition of the alloys. Results obtained 
from SEM/EDS tests are presented in Table 3-6 and Table 3-7. 
 
Figure 3-21: SEM/EDS equipment 
The results obtained from the SEM tests on the alloys before the heat treatment 
process confirmed that the alloys were of β phase structure with large crystals 
spanning millimetres squared. The darker areas present, in particular in alloys 
Ti35Nb4Sn and Ti35Nb14Ta, are due to superficial stresses created during rapid 
cooling in the arc melting process. Most of them disappeared in the images obtained 
after heat treatment, confirming it was a casting effect on the surface of the sample as 
shown in Table 3-5. The EDS results obtained from the test did not detect any 
contamination in the samples. Ti, Nb,Sn and Ta were only the elements shown in the 
results in Table 3-7. Furthermore, the proportions (%wt) corresponded to those 
intended in their inception and confirmed a good alloying among them.   
 
a b 
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Table 3-6: SEM/EDS results for all alloys before heat treatment 
Alloy Before Heat Treatment 
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Table 3-7: SEM/EDS results for all alloys after heat treatment 
Alloy After Heat Treatment 
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3.4.7.4 X-ray Diffraction (XRD) 
X-ray diffraction measurement tests were conducted using a bench top Bruker 2D 
phaser θ/2θ, Germany. The sample was placed in a plastic holder and levelled precisely 
to be able to achieve an optimum beam focusing. After that, the sample was inserted in 
a stage inside the XRD machine. The stage moved to the 2θ position for reflecting and 
receiving X-ray beam. The test was performed with a 2θ angle range from 30 to 90°, 
and with a step size of 0.050823°. 
The results obtained from the XRD tests report that all the four alloys tested before 
the heat treatment exhibited a β phase structure as shown in Figure 3-22, the Ti sample 
before and after heat treatment exhibited an α (HCP) crystal structure, as expected. It 
can be observed that Ti35Nb14Ta has higher intensity at 38.3° angle compared to the 
other three alloys, a sign of a more crystalline structure. This was also true on the alloys 
after heat-treatment. 
 
Figure 3-22: XRD results for all alloys before heat treatment  
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XRD results for the alloys after heat treatment are shown in Figure 3-23  and also 
exhibit clear β peaks. When comparing the results obtained before and after heat-
treatment, significant differences can be observed. The peak at 83° decreased after 
heat treatment for the alloy Ti35Nb14Ta. The peaks at 55° and 70° broadened, 
potentially indicating the twinning into an α” phase, an indication of superelasticity.  
For Ti37Nb6Sn, the dominant β peak at 38° and peak at 55° became more 
prominent (i.e. more crystalline) after heat-treatment. On the contrary, the peak at 70° 
decreased with heat-treatment, contribution to a more marked (BCC) cubic crystal 
structure.  
The intensity of the dominant β peak at 38° did not change for Ti35Nb4Sn when 
comparing before and after heat-treatment. However, the peaks at 55° and 83°, almost 
disappeared and the one at 70° not only increased its intensity but also broadened 
towards the left-hand side, a clear indication of the presence of α” phase.  
Likewise, for Ti30Nb4Sn, the intensity of the dominant peak remained unchanged 
with heat-treatment, the peak at 55° disappeared, conversely the peak at 70° 
decreased but still broadened (α” formation) and a small peak at 83° appeared with a 
slight broadened or double peak.    
 
Figure 3-23: XRD results for all alloys After heat treatment 
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3.4.7.5 Mechanical Testing 
Three different tests were conducted to investigate the mechanical properties of 
the alloys. The first method was a compression test performed in a range of 
temperatures. The compressive test was chosen to be able to discover if the carrier can 
withstand the loads and the conditions inside the human body.  An Instron model 3369 
Universal testing machine (UTM), with a built-in furnace and load cell of 50 kN, as 
shown in Figure 3-24, was used to apply a fixed load on the samples at various 
temperatures. 
         
Figure 3-24: Universal testing machine with built-in furnace  
The sample was placed in the furnace between two moving plates. A metallic 
extension was used to reduce the movement between the plates as shown in Figure 
3-24. The load was fixed at 2.5 kN and 5 kN, which is within the elastic range of the 
material to avoid any plastic deformation in the samples, with a temperature range 
from room temperature to 120°C for each cycle of the test. A Bluehill software, 
uploaded in a computer and connected to the machine, was used to control the load, 
movement rate and the end of the test. The dimensions of the samples were measured 
by digital Vernier calliper with an accuracy of 0.01mm and entered in the software 
interface to measure the changes in dimensions due to compression load and the 
thermal stress during the test. The samples were made with 8 mm diameter and 17 
mm in length. 
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The temperature was recorded every minute and the compression extension 
versus time. The strain was plotted against temperature and stress to know the effects 
of changing the temperature on the behaviour of the alloys. This test was performed 
with the alloys before and after heat treatment. Results obtained for the alloys before 
and after heat treatment are presented in Figure 3-25, Figure 3-27, Figure 3-29 and 
Figure 3-31. While the results for the alloys under 2.5kN and 5kN are presented in 
Figure 3-26, Figure 3-28, Figure 3-30 and Figure 3-32. 
Figure 3-25:Ti30Nb4Sn before and after Heat treatment 
 
Figure 3-26: Ti30Nb4Sn before Heat treatment under 2.5kN and 5kN load 
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The results for Ti30Nb4Sn showed a change in the compressive strain value after 
the heat treatment due to the presence of the α” phase microstructure in the cast 
samples.  
While Ti35Nb4Sn results showed the same value for the compressive strain before 
and after the heat treatment process as shown in Figure 3-27. The results for the 
samples under 2.5 kN and 5kN load showed the same results but due to an error 
occurred in the software while performing the test, the results appeared in positive 
and negative values as shown in Figure 3-28.  
 
Figure 3-27: Ti35Nb4Sn before and after Heat treatment 
 
Figure 3-28: Ti35Nb4Sn before Heat treatment under 2.5kN and 5kN load 
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The results obtained for Ti37Nb6Sn exhibited the same values before and after the 
heat treatment process because the microstructure only contained β before and after 
heat treatment as shown in Figure 3-29. While the results obtained with different load 
showed a slight difference that occurred due to the different load conditions.   
 
Figure 3-29: Ti37Nb6Sn before and after Heat treatment  
 
Figure 3-30: Ti37Nb6Sn before Heat treatment under 2.5kN and 5kN load 
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Ti35Nb14Ta results showed the same values for the compressive strain before and 
after the heat treatment as shown in Figure 3-31. The results confirmed the influence 
of adding Ta as a third alloying element to TiNb alloys. The addition of Ta reduced the 
stiffness value for the alloy and stabilised the β phase. The same error occurred during 
the test with different loads changed the valued obtained from negative to positive 
values.   
 
 
Figure 3-31: Ti35Nb14Ta before and after Heat treatment 
 
Figure 3-32: Ti35Nb14Ta before Heat treatment under 2.5kN and 5kN load 
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Following that, a compression test was conducted for the heat treated alloys 
without applying any heat during the test. The samples were placed in a Universal 
testing machine(UTM, Instron machine model 3369), as shown in Figure 3-33,  
equipped with 50 kN load cell. The dimensions of the samples were recorded using a 
digital vernier calliper and entered into the Bluehill software interface. The samples 
were placed between the two plates and the upper plate moved at a rate of 10-4  mm/s 
until the compression load reached 15kN. Then, the load was released at the rate of 10-
3 mm/s until the load reached zero, registering the residual strain.  
       
Figure 3-33: Compression test without applying heat  
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Strain-stress graphs (Figure 3-34) were obtained using the following equations.  
For stress: 
𝜎𝑒 =
𝐹
𝐴
 3.3 
 
And for strain: 
𝜀𝑒 =
∆𝑙
𝑙0
=
𝑙0 − 𝑙
𝑙0
 3.4 
 
 
Figure 3-34 : Stress-strain charts for the alloys under study without temperature 
The load was chosen to be 15kN, which is within the elastic region of the alloys. It 
was important to ensure that the alloys were not compressed with a load extending 
beyond the yield point and therefore deform the alloy permanently. The residual strain 
upon unloading was recorded.  
From the results, Ti35Nb4Sn exhibit a residual strain of 0.3% while Ti30Nb4Sn 
displays only 0.2% of residual strain. Ti37Nb6Sn had only 0.1% residual strain and the 
alloy containing 14%wt of Ta returned to the original status after removing the load at 
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the end of the test (i.e. zero residual strain). The nonlinearity results from the 
compression within the Instron testing machine under the test conditions. However, 
after increasing the load to a higher value in the test reached the yield stress the results 
were linear for all the alloys as shown in Figure 3-36. Also, another reason could be the 
difference in stiffness values for the alloys. Ti35NbTa alloy which has the lowest 
Young's modulus value exhibited a linear result.   
After conducting the test, the samples were reheated in a ceramic tube furnace to 
remove any residual strain accumulated due to the compression test. The heating 
process was performed at a heating rate of 3 °C/min and a temperature of 900 °C for 
12 hours as shown in Figure 3-35.  
 
Figure 3-35: Reheating process to remove residual strain  
After the reheating process, a subsequent test was conducted to obtain the Young’s 
Modulus of the alloys after being heat treated. The load was applied on the sample until 
the alloy reached the yield point and then the load was removed before the alloy 
deformed plastically. The load was controlled manually by observing the behaviour of 
the material under the load. Different yield points were recorded for the different 
alloys. A comparison of the alloys was plotted in the stress-strain graph as shown in 
Figure 3-36.   
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Figure 3-36: Stress-strain curve up to yield points for all alloys after heat-treatment 
Finally, a third test was performed to investigate the superelasticity effect of the 
alloys. Cyclic deformation tests were conducted to reach 2% strain on loading and then 
unloaded, repeating five cycles at room temperature. A preload of 0.3N was applied to 
the sample with a strain rate of 0.005 mm/s. After the preload step, the load was 
applied with a strain rate of 0.001 mm/s. The results for each alloy were plotted and 
are presented in Figure 3-37,Figure 3-38, Figure 3-39 and Figure 3-40. 
The results obtained for all the alloys exhibited a superelasticity even after the five 
cycles of loading and unloading test. The samples were able to return to it is original 
size without being deformed or storing strain. The samples were able to withstand a 
stress around 350 MPa which is 2% strain for the samples.  
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Figure 3-37: Cyclic deformation test for Ti30Nb4Sn to reach 2% strain 
 
Figure 3-38: Cyclic deformation test for Ti35Nb4Sn to reach 2% strain 
 
Figure 3-39: Cyclic deformation test for Ti37Nb6Sn to reach 2% strain 
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Figure 3-40: Cyclic deformation test for Ti35Nb14Ta to reach 2% strain 
The Young’s Moduli obtained from the tests are presented in Table 3-8: 
Table 3-8: Young’s moduli obtained from the stress-strain graph  
   Alloy Young’s Modulus 
(GPa) BH 
Young’s Modulus 
(GPa) AH 
Ti30Nb4Sn 33.81 14.79 
Ti35Nb4Sn 46.65 14.97 
Ti37Nb6Sn 70.10 15.18 
Ti35Nb14Ta 32.40 17.36 
 
3.4.7.6 Hardness test 
The Vickers hardness test was performed to explore the hardness values for the 
alloys before and after the heat treatment process. The samples were prepared by 
mounting them in cold mounting resin and then polished to have a mirror finished 
surface. 
The test was conducted using a Struers DuraScan-70 machine as shown in Figure 
3-41. The machine was connected to a computer to control the test parameters. The 
sample was loaded onto the machine and held in place with BlueTak® to avoid any 
movement during the test due to the load applied by the indenter.   
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Figure 3-41: Microhardness test machine and sample setting  
The test setup was programmed to do a mapping test at several location points. 
Nine points were chosen to measure the hardness for each sample as shown in Figure 
3-42.  The distance between each point was chosen to be 2 mm apart to cover as much 
area as possible. After choosing the test points, a touch from the indenter in the highest 
point on the sample was done to calibrate and adjust the height of the sample for 
accurate and precise results. The calibration was important to ensure the sample was 
levelled and the indenter measurement was accurate.  
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Figure 3-42: Hardness test points mapping 
At each point, the indenter held a load of 10 kg (98.1 N) for 10 seconds. The 
indenter produced an indent on the sample surface as shown in Figure 3-43 and the 
dimensions of the indent were measured by the software.    
 
Figure 3-43: Indent shape and size 
The results obtained from the machine were recorded and plotted as shown in Figure 
3-44, Figure 3-45, Figure 3-46  and Figure 3-47. The average hardness value for each 
alloy, before and after heat treatment, was calculated and is presented in Table 3-9.  
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The results from the hardness test for Ti30Nb4Sn showed that the hardness value 
ranged from approximately 282 HV to 319 HV before the heat treatment as shown in 
Figure 3-44. Though, the harness value increased after heat treatment to range from 
310 HV to 330 HV which confirms the influence of the heat treatment on the hardness 
value of the alloy.     
 
Figure 3-44: Hardness test before and after heat-treatment for Ti30Nb4Sn 
For the alloy Ti35Nb4Sn the hardness value increased by increasing the amount of 
Nb in the alloy. The hardness value ranged from 295 HV to 320 HV before the heat 
treatment. Although, the hardness value affected by the heat treatment and increased 
as shown in Figure 3-45. 
 
Figure 3-45: Hardness test before and after heat-treatment for Ti35Nb4Sn 
270
280
290
300
310
320
330
340
350
0 1 2 3 4 5 6 7 8 9 10
H
ar
d
n
e
ss
 (
H
V
)
Test Points
BH AH
270
280
290
300
310
320
330
340
350
0 1 2 3 4 5 6 7 8 9 10
H
ar
d
n
e
ss
 (
H
V
)
Test Points
BH AH
                            Catalyst Carrier 
76 
 
The hardness value for the Ti37Nb6Sn influenced by increasing the amount of Nb 
and Sn more than the other alloys. By increasing the amount of Nb an Sn by 2% the 
hardness value increased to a range from 310 HV to 322 HV. Also, the heat treatment 
process affected the hardness value to be more than 330 HV and reach up to 340 HV.  
 
Figure 3-46: Hardness test before and after heat-treatment for Ti37Nb6Sn 
Changing the third alloying element to Ta influenced the hardness value. The 
hardness value ranged from 300 HV to 318 HV before the heat treatment and increased 
to approximately 350 HV after the heat treatment process.  
 
Figure 3-47: Hardness test before and after heat-treatment for Ti35Nb14Ta 
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3.5  Chapter summary 
In this chapter, the results from the manufacture and characterisation of the 
carrier have been presented. All the alloys fabricated exhibited no contamination and 
confirmed the composition of the elements added to the alloys by the analysis methods. 
The phases obtained met the expected phases during the designing stage. The results 
of the DSC test showed an influence of the heat treatment in the transformation 
temperature and the hardness values of the alloys. Young’s moduli of the alloys were 
reduced by changing the alloys compositions and applying heat treatment. The yield 
stress was affected by the alloy’s compositions.  a summary table compiling all relevant 
data is presented below:  
Table 3-9: Transformation phases and mechanical properties for all alloys 
 
 
Expected Alloy 
 
Ti30Nb4Sn Ti35Nb4Sn Ti37Nb6Sn Ti35Nb14Ta 
Actual Alloy 
 
Ti30.6Nb4.3Sn Ti35.8Nb4.5Sn Ti36.1Nb6.2Sn Ti34.5Nb14.7Ta 
Expected phase 
 
β + α β β β 
Actual phase 
 
β + α” β β β 
Transformation 
Temperature BH 
(°C) 
78 123 43 30 
Transformation 
Temperature AH 
(°C) 
56 48 58 Not detected 
Hardness BH 
(HV)(SD) 
304 (9.45) 306 (6.49) 312 (3.46) 307 (4.96) 
Hardness AH 
(HV)(SD) 
319 (4.83) 318 (3.62) 332 (2.92) 339 (4.08) 
Young’s modulus BH 
(GPa)  
33.81 46.65 70.10 32.40 
Young’s modulus AH 
(GPa)  
14.79 14.97 15.18 17.36 
Yield Stress (GPa) 
AH 
537 565 609 621 
Residual strain (%) 0.2 0.3 0.1 0.0 
Superelasticity Not fully No Yes Yes 
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4 Palladium coating deposition 
4.1 Introduction 
In this chapter, the methodology of the coating processes used in this research is 
presented, evaluated and explained alongside an explanation of the results obtained 
from the experimental work and the characterisation methods employed.  
4.2 Manufacturing protocols used to deposit Palladium coating   
4.2.1 Sintering method (S) 
Palladium powder (<75µm particle size, 99.9% purity, from Aldrich company, UK) 
was used to fabricate palladium wafers. An appropriate quantity of palladium powder 
was poured into a 10 mm stainless steel mould as shown in Figure 4-1. The mould was 
designed to use less palladium powder to fabricate the samples instead of using the 
mould of 16 mm diameter used to fabricate the carrier in chapter 3. Then, it was cold 
pressed by a pressing machine (Press 40 Specac, Atlas,UK) applying a vertical load of 
20 kN. The pressing step was performed to form a green body sample and strengthen 
the bonds between the particles of the metal powder. After that, the green body 
samples were inserted into a ceramic tube furnace (LTF1400°C, Lenton, USA) to be 
sintered. The sintering process was performed to fuse the bonds in the green body. The 
samples held in the furnace for 1 hour at a temperature of 1000°C. The furnace tube 
was connected to a vacuum pump (HiCube 80, Pfeiffer, Germany) to create a vacuum 
atmosphere to the level of 10e-5 mbar to avoid any oxidation during the sintering 
process. The samples were left to cool down naturally to room temperature. After that, 
the wafers were polished manually using 320 and 1200 grit SiC paper until shiny finish. 
Samples were prepared in triplicate and used without any further treatment. 
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Figure 4-1: Schematic of the pressing operation for (S) samples 
4.2.2 Sintering with carrier (Sc) 
Samples were prepared after choosing powder metallurgy as the technique for 
manufacturing, by pressing the titanium and palladium powders using the pressing 
machine as mentioned in section 4.2.1. Also, two different types of palladium were 
used, palladium granules (-22 mesh, particle size 840µm, 99.995% purity, Alfa Aesar 
Company, UK) and palladium powder (<75µm particle size, 99.9% purity, from Aldrich 
company, UK), to compare surface roughness between them. Titanium powder (-325 
mesh, particle size 0.044 mm, 99.5% purity packed under Argon, from Alfa Aesar 
Company, UK) was used as the main material to prepare the samples. It was used as 
the carrier material for the palladium.  The mould had been previously designed and 
cleaned using Ethanol (denatured, 85.4% purity, liquid, from Alfa Aesar Company, UK) 
and Acetone (≥ 99.8% purity, liquid, from Sigma-Aldrich Company, UK). Titanium 
powder was poured into the stainless-steel mould first, waiting for palladium powder 
to be put on the top before being pressed as shown in Figure 4-2. The sintering process 
was performed to fuse the bonds in the green body. The samples held in the furnace 
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for 2 hours at a temperature of 1200°C. The furnace tube was connected to a vacuum 
pump (HiCube 80, Pfeiffer, Germany) to create a vacuum atmosphere to the level of 
10e-5 mbar to avoid any oxidation during the sintering process. The samples were left 
to cool down naturally to room temperature. After that, the samples were polished 
manually using 320 and 1200 grit SiC paper until shiny finish. The samples were 
prepared in triplicate and used without any further treatment.  
 
 
Figure 4-2: Schematic of the pressing operation for (Sc) samples 
4.2.3 Sintering with space-holder (Sx) 
The samples were prepared by using Titanium powder (-325 mesh, particle size 
0.044 mm, 99.5% purity packed under Argon, from Alfa Aesar Company, UK), 
palladium powder (<75µm particle size, 99.9% purity, from Aldrich company, UK), 
space holder materials and solvents. Titanium powder was used as the base metal for 
all samples. In these samples, the substrate and the coating layer were fabricated at the 
same time.  Palladium powder was mixed with two types of space holder particles for 
comparison purposes. The first type was ammonium bicarbonate (NH4HCO3) 
(BioUltra, ≥99.5% purity, a density of 1.580 g/cc, from Sigma-Aldrich Company, UK) 
and the second type was Sodium chloride (reagent grade, ≥ 98% purity, +80 mesh, 
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particle size 0.177 mm, from Sigma-aldrich Company, UK) in four particle sizes ranging 
from 45 to 212 µm. Titanium powder was poured into the stainless-steel mould and 
then the mixture of palladium powder and the space holder was added on top. Then, 
the mixture of powders was pressed as shown in Figure 4-3. The sintering process was 
performed to fuse the bonds in the green body. The samples held in the furnace for 2 
hours at a temperature of 1200°C. The furnace tube was connected to a vacuum pump 
(HiCube 80, Pfeiffer, Germany) to create a vacuum atmosphere to the level of 10e-5 
mbar to avoid any oxidation during the sintering process. The samples were left to cool 
down naturally to room temperature. Samples were prepared in quadruplicate and 
used without further treatment.  
 
Figure 4-3: Schematic of the pressing operation for (Sx) samples 
4.2.3.1 Calcination of space-holder  
The Calcination of the space holder is a thermal treatment used to remove the 
space holder from the sample and therefore increase roughness as well as surface area 
on the coating. The sample is heated to a temperature above the melting point of the 
space holder material which escapes in the open furnace.  
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The two space holders used in this study possess very different melting 
temperatures. Ammonium bicarbonate (NH4HCO3) has a melting point of 41.9°C which 
is lower than the melting point of palladium and titanium and other space holders. 
Therefore, the powders will not be affected by the temperature required to remove the 
ammonium bicarbonate from the samples. In this way, the calcination process was 
performed by heating up the samples to 135 °C with a heating rate of 5°C per minute 
dwelling for 2 hours and left to cool down naturally.   
To confirm the space-holder was totally removed from the sample, the total weight 
of the sample is measured before and after each cycle of the calcination process. Using 
the equation below to calculate the space holder removal: 
 
𝑠𝑝𝑎𝑐𝑒 − ℎ𝑜𝑙𝑑𝑒𝑟 𝑟𝑒𝑚𝑜𝑣𝑒𝑑 % =
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡−𝑓𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡 
𝑜𝑟𝑖𝑔𝑖𝑛𝑎𝑙 𝑤𝑒𝑖𝑔ℎ𝑡
∗ 100                         4.1 
 
After three cycles of removing the space-holder from the samples, the total weight 
of the removed material was recorded as shown in table 1. The percentage of the 
ammonium bicarbonate removed from the sample was below 59 % of the weight of 
ammonium bicarbonate used in manufacturing the sample in all cases. This 
measurement has limitations because the accuracy of bulk weight measurements is 
not as good as more sophisticated quantitative methods such as EDX.  
Table 4-1: Weight and percentage of space-holder removed from the samples 
Sample Ti (g) 
Pd 
(g) 
NH4HCO3 
(g) 
Total 
weight 
(g) 
After 
compressing 
(g) 
After 
calcination 
(g) 
Weight 
lost (g) 
NH4HCO3 
removed % 
1 0.3593 0.218 0.035 0.6123 0.5971 0.5758 0.0213 57.58 
2 0.353 0.226 0.0352 0.6142 0.5911 0.5681 0.023 56.81 
3 0.357 0.214 0.0382 0.6092 0.6075 0.5832 0.0243 58.32 
4 0.354 0.225 0.0358 0.6148 0.5927 0.5662 0.0265 56.62 
 
For the other space holder used, Sodium Chloride (NaCl), a different approach was 
needed because its melting temperature is in the order of 800°C (or beyond) and 
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therefore a calcination process would affect (i.e. oxidise) them. However, NaCl has the 
advantage of being soluble in water, so distilled water (locally produced) was 
employed to dissolve the space holders by washing after sintering.  The process of 
removing the space holder from the samples was performed in several cycles to ensure 
all the space holder material was removed. The first stage was washing the samples 
after sintering with distilled water to remove the space holder and then, heating the 
samples up to 100°C to dry them and remove any moisture or water remaining from 
the washing process.   
A sintering process followed for the green body. This follows the calcination 
process for ammonium bicarbonate samples, but it precedes the washing-off when 
Sodium Chloride is used as a space holder because the water could damage the green 
body.     
Prior to the application, the space-holder material was sieved using a sieving 
machine (AS400 control, Retsch, Germany) and graded to four different sizes. The sizes 
were classified as follows: Si= 45-106 µm, Sii= 106-212 µm, Siii= >212 µm and Siv= 45-
212 µm in random distribution.   
4.2.4 Magnetron Sputtering Deposition (SP) 
4.2.4.1 Preparation of the substrates   
The substrates were prepared using Titanium powder (-325 mesh, particle size 
0.044 mm, 99.5% purity packed under Argon, from Alfa Aesar Company, UK). The 
substrates were manufactured by the Powder Metallurgy technique as explained in 
chapter 3. The powders were pressed into their shape using a stainless-steel die of 16 
mm in diameter. Then, the samples were sintered in the vacuum furnace to the level 
1e-5 mbar to avoid any oxidation in the samples. The sintering process for these 
substrates was performed differently from the previous sample. They were sintered at 
1200°C for 2 hours. After that, the substrates were polished based on the 
recommended procedure. These substrates were polished using a polishing machine 
(EcoMet250 and AutoMet250, Buhler, USA) with 320 grit SiC paper with a speed of 180 
rpm, water cooled, and 15 N load/specimen with a rotation of the head holder in the 
same direction until getting a flat surface. The same steps were repeated with 600 and 
1200 grit papers to reduce the roughness of the surface. And then polished with 9 μm 
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diamond suspension on an ultra-pad cloth with a speed of 120 rpm, and 15 N 
load/specimen with a rotation opposite to the platen for 10 minutes. The final 
polishing step had the same parameters but with 1 μm colloidal silica on a microcloth 
pad. The substrates measured approximately 2 mm in thickness and had a diameter of 
around 16 mm. The samples were washed with distilled water (locally produced) and 
acetone (≥ 99.8% purity, liquid, from Sigma-Aldrich Company, UK) prior to the 
deposition step. 
4.2.4.2 Palladium deposition  
The Palladium coatings were applied using a magnetron sputtering system. The 
sputtering process was performed in the laboratory using a sputtering machine from 
Quorum Company (Q150T ES, Quorum Technologies Ltd, UK) as shown in Figure 4-4. 
The machine was set up to do the coating of the palladium using a palladium target 
((Pd) target, 99.99% purity, 57 mm diameter x 0.1 mm thickness, from PI-Kem Limited 
Company, UK). The thickness of the coating was decided according to the mass 
required to be deposited of the palladium on the substrates.  
 
 
Figure 4-4: Magnetron sputtering/ coating system 
The substrates were placed on the sputtering stage and distributed around the 
centre as shown in Figure 4-5. The chamber was flushed with Argon gas prior to the 
sputtering process. The sputtering was performed under a vacuum atmosphere and 
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pure Argon gas. The process pressure was 9x10-3 mbar and the current was 40 mA. The 
deposition rate of the coating was set to 21 nm/min.   
 
 
Figure 4-5: Substrates placed in the sputtering machine 
The samples were coated with Pd film with a thickness of 62.8 nm. The thickness 
of the coating was controlled by the thickness gauge directed on the machine as shown 
in Figure 4-5 with an arrow. Samples were prepared in quadruplicate and used without 
further treatment.  
4.2.5 Pulsed Laser Deposition (PLD) 
4.2.5.1 Preparation of the substrate  
In this experiment, the substrates were manufactured and prepared using the 
same procedure as used in the magnetron sputtering process. They were 
manufactured by powder metallurgy technique, polished and cleaned with the same 
procedure explained earlier in the magnetron sputtering section.  Samples were 
prepared in duplicate and used without further treatment.  
4.2.5.2 Palladium deposition 
The substrates were mounted on the substrate holder designed and fabricated in 
the laboratory to hold the substrate on the top of the target and to perform deposition 
over large areas. The bespoke holder was made of stainless steel which is suitable for 
the vacuum system. Then, it was heated to 120 °C and set to vacuum to reach the base 
pressure of 1e-9 mbar. After that, it was left to cool down naturally to room 
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temperature. It took 24-48 hours. Palladium ((Pd) target, 99.99% purity, 15 mm x 15 
mm x 2 mm thickness, from Testbourne Ltd Company, UK) was used. 
The palladium was deposited at room temperature using an 840 mW power pulsed 
laser. The distance between the target and the substrate was 10 cm. The number of 
pulses was set up as 10 pulses per second and the laser beam was visible light at 526 
nm wavelength. Each deposition took 2.5 hours and it aimed a thickness of 65 nm on 
each substrate.  The samples were prepared in duplicate and used without further 
treatment.  
4.2.6 Supersonic Cluster Beam Deposition (SCBD) 
4.2.6.1 Preparation of the substrate 
In this coating process, the same size substrates were used and prepared in the 
same procedure as mentioned in the other two coating processes. They were 
manufactured by powder metallurgy technique using Titanium powder, polished and 
cleaned with the same procedure explained earlier in the magnetron sputtering 
section.  Only one substrate was prepared to be coated with Palladium to examine the 
procedure of the coating.  
4.2.6.2 Palladium Deposition  
The substrate was sent to University of Milano, Italy (Prof. M Milani’s lab) to be 
coated with palladium. The reason behind that was the availability of the coating 
machine in University of Milano as it was not available at Loughborough University. A 
Palladium rod((Pd) target, 99.99% purity, 15 mm x 15 mm x 2 mm thickness, from 
Testbourne Ltd Company, UK) was used as a target and the palladium was deposited 
typically using a pulsed microplasma source with the rate of 0.5 nm/min. The thickness 
of the coating was requested to be around 50 nm. Once received from Italy, the sample 
was used without further treatment.  
4.2.6.3 Characterisation of the palladium coating 
The characterisation of the samples in this part of the research involved different 
methods. Scanning electron microscopy (SEM) was used in this research to take 
magnified images of the sample surfaces. SEM machine was an important tool to be 
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used in this research to evaluate the topography and characteristics of the top surface 
of each sample, examine the roughness of the surface and the uniformity of the coating.  
Furthermore, the EDS technique was used in this research to identify the elements 
contained on the coating of the samples, including any contamination, e.g. any 
oxidisation due to the lack of vacuum or any other reasons.  
Also, X-ray diffraction (XRD) tests were conducted to assess the crystal structure 
of samples and the palladium coating and ensure there was no alloying between the 
carrier and the coating film, an important design specification in this application.  
Surface texture measurement, 3D micro coordinate measurement machine and 
surface roughness measurement device (Alicona InfiniteFocus, Taylor Hobson, UK) 
was used to measure the surface area of the material and its roughness. The calculated 
area of the surface can be used to calculate the mass of the palladium applied to the 
carrier. 
To measure the quantity of palladium deposited onto the carrier, X-ray 
fluorescence (XRF) tests were conducted on these samples to measure the thickness of 
the coating. More than one spot was scanned to measure the average thickness and the 
uniformity of the coating. From these measurements, the thickness of the coating can 
be used to calculate the mass of the palladium applied. 
Atomic force microscopy (AFM), and Transmission electron microscopy (TEM), 
using focused ion beam (FIB) to lift out thin slices of the samples, were techniques used 
to validate the thickness measurements.  
Furthermore, X-ray photoelectron spectroscopy (XPS) was used to identify the 
electronic state of the elemental composition and any Pd oxide contamination present. 
It was also employed to measure the coating thickness by conducting a depth profile 
method. More details about the characterisation methods and the results obtained 
from these tests will be presented in the next sections.  
 
 
                                                                                      Palladium coating deposition 
88 
 
4.3 Characterisation results  
4.3.1 XRD results for all coated samples 
The coated samples were characterised by XRD to determine the elements in the 
sample and their metallic states. The results obtained for the sintered wafers (S) and 
sintered with carrier samples (Sc) were a single Pd cubic state element with no other 
accompanying peak, while the samples sintered using space holders exhibited the 
presence of TiO2 in addition to metallic Ti and Pd in the samples. The existence of TiO2 
in these samples could be due to the reaction occurred between Ti and NaCl as 
mentioned in literature (167). On the other hand, the other samples, manufactured by 
SCBD, PLD and SP processes, showed only Ti and Pd species in their cubic state as 
shown in Figure 4-6. 
 
 
Figure 4-6: XRD for all coated carriers
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4.3.2 XPS results for all coated samples 
XPS tests were conducted to ensure the presence of Palladium in its metallic form 
(i.e. Pd0). The data was analysed and fitted by using NIST Standard Reference Database 
20, Version 4.1 (168). The results obtained from XPS showed 2 dominating peaks at 
335.33±0.06 eV and 340.85±0.26 eV for Pd3d5/2 and Pd3d3/2 respectively as shown in  
 
Figure 4-7: XPS for all coated carrier
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. These two peaks confirm that Pd exists in their metallic state. In addition, O1s 
peak appears at 527eV and 562 eV which could correspond to the background signal 
not the formation of Pd0. Otherwise the peak would be shifted and had appeared at 
530.3eV.  The shifted peak for O1s confirms that there was no presence of Pd0 in these 
samples.  
Furthermore, a peak for carbon appears in all the samples. The peak of C1s appears 
around 248 eV which corresponds to the sp2 carbon peak. However, after argon 
etching took place, the intensity of the peak decreased which confirms it was only 
superficial contamination on the surface.    
 
 
Figure 4-7: XPS for all coated carrier
S & Sc Samples  
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4.3.3 Surface area and mass of Palladium 
The quantity of palladium deposited was measured and calculated using different 
methods. It was necessary to identify the amount of palladium deposited to determine 
the efficiency of the device with the prodrug.  These methods entailed weighing the 
amount of powder used in fabricating such layer, XRF, AFM and FIB/SEM tests. The 
total surface area was measured by using 3D microscopy. The total amount of Pd 
deposited (in mass) was calculated by measuring the thickness of the coating layer and 
multiplying by the surface area, then multiplying by the density of Pd. Surface area, 
thickness, mass and ratio between area and mass are presented in Table 4-2. 
The surface area of the wafers was measured using a 3D micro coordinate 
measurement machine and surface roughness measurement device (InfiniteFocus 
Alicona, Austria). The measurement was conducted using metrology protocols with x5 
magnification with a vertical and horizontal resolution of 3.22 µm and 7.82 µm 
respectively. Also, polarised light was used to reduce the reflection from the shiny 
surface of the samples. The measuring machine was used because of the shape of the 
wafers after the sintering process had changed. The measurement was done on both 
sides of the wafers and the total surface area for each sample calculated as the sum of 
both.   
The surface shape and profile were obtained by the 3D micro coordinate 
measurement machine shown in Figure 4-8. 
 
Figure 4-8: Surface profile for palladium wafers: a) top side b) bottom side 
 
a b 
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The surface area of the samples prepared by the sintering method with space-
holder was measured using the machine as mentioned in section 4.3.3. The profile 
showed different surface roughness for each space-holder size.   
 
 
 
Figure 4-9: Surface profile for different space-holders samples: a) (45-106) µm b) 
(106-212) µm c) (<212) µm d) (mix) µm 
SEM images for the four different space holder sizes showed different surface 
roughness as shown in Figure 4-10    
 
 
 
Figure 4-10: SEM images for (Sx) samples with different roughness 
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The samples coated by sputtering, pulsed laser deposition and supersonic cluster 
beam deposition methods presented more challenges due to the thickness of the 
coating (i.e. in the nanometre range). 
The main method used for measuring the thickness of the coating was X-ray 
fluorescence. The machine (Orbis PC micro-XRF analyser, EDAX, USA) is equipped with 
a Rh tube of 50 kV and 50 W. Five points were measured systematically (i.e. centre, top, 
bottom, left and right). 
Furthermore, Atomic Force Microscopy (AFM, Veeco Explorer, USA) was used to 
confirm the thickness obtained by the XRF method. The measurement was performed 
by using a Si cantilever (AFM probe-Bruker TESP-MT) and applying a force of 20-80 N 
m-1 at 330 kHz of resonance frequency. Three areas were selected randomly, and the 
images obtained were analysed using the XEI 1.8 software (Park systems, South Korea) 
as shown in Figure 4-11.  
 
 
Figure 4-11: AFM measurement for coating thickness 
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In addition, Focused Ion Beam (FIB) system (Nova200 NanoLab, FEI, USA) was 
used to obtain thin slices of the samples in order to measure the thickness of the 
coating using SEM images. A sample of 15 µm length and around 4 µm width was cut 
by FIB as shown in Figure 4-12.  
 
Figure 4-12: Slice obtained from the sample by FIB 
 
 
Figure 4-13: SEM image for coated sample with measurement, (inset: profile of 
the Pd layer) 
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Table 4-2: Measured surface area and mass of Pd for the Ti-[Pd] devices 
Manufacturing 
method 
Sample 
Surface 
Area 
(mm2) (SD) 
Thickness of 
Pd (nm) 
Mass of Pd 
(SD) 
Ratio 
A(mm2):W(g) 
(SD) 
Sintering(S) Pd Wafer 142.013* 
(6.039) 
n/a 0.162 g 
(0.014) 
876.624 
 (80.459) 
Sintering with 
carrier (Sc) 
Sintered Ti 
base/ layer 
of solid Pd 
101.21 
(5.042) 
n/a 0.521 g 
(0.0065) 
194.261 
(5.042) 
Sintering with space holder on Pd layer (Sx) 
Si Size range:  
45-106µm 
147.577 
(6.842) 
n/a 0.210 g 
(0.005) 
702.748 
 (36.626) 
Sii 106-212 
µm 
144.835 
(26.095) 
n/a 0.209 g 
(0.007) 
692.990 
(126.995) 
Siii >212 µm 135.560 
(11.960) 
n/a 0.206 g 
(0.001) 
658.058 
(120.594) 
Siv random 114.095 
(12.445) 
n/a 0.209 g 
(0.000) 
545.909 
 (59.545) 
Sputtering 
(SP) 
Sintered Ti 
base/Pd 
coating 
172.322 
(6.251) 
67.600 
(3.226) 
[65.028]AFM 
[66.706]FIB/SEM 
0.138 mg 
(0.005) 
1248.710 e3 
(62.658 e3) 
Pulsed Laser 
Deposition 
(PLD) 
Sintered Ti 
base/Pd 
coating 
187.43 
(12.093) 
69.085 
(1.515) 
[66.30]AFM 
 
0.153 mg 
(0.001) 
1225.033 e3  
(112.579 e3) 
Supersonic 
cluster beam 
deposition 
(SCBD) 
Sintered Ti 
base /Pd 
coating 
212.550 
(7.640) 
50.76 (14.75) 
[50.5]AFM 
0.130 mg 
(0.038) 
1635.0 e3  
(481.523 e3) 
*Total surface area, including both sides. [..] AFM or FIB/SEM, thickness confirmed by using 
these methods.  
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The surface area for all the devices was different based on the surface roughness 
and the size of the carrier. The surface area for the sintered and sintered with space 
holder samples ranged from 101 to 147 mm2  . While the samples coated with the other 
coating processes ranged from 172 to 212 mm2 . however, the amount of the palladium 
deposited on the carrier using the sintering methods was ranged from 0.162 g to 
0.521g which is high compared to the amount deposited by the physical vapour 
deposition methods. The amount of palladium deposited by supersonic cluster beam 
deposition was the lowest which was 0.130 mg and the highest was 0.153 mg for the 
pulsed laser deposition method.    
4.4  Catalytic and Biological Test  
A biological test was kindly performed in collaboration with the Cancer Research 
UK Edinburgh Centre, at the University of Edinburgh. The test was conducted to 
determine the catalytic effect of the samples with the prodrug. Fluorescence properties 
were assessed to determine the catalytic efficiency of each of the devices. Also, a 
reusability study was performed to ensure Pd will last after continuous use and can be 
removed from the human body after the treatment. The efficiency of the palladium 
devices was determined by the conversion of the non-fluorescent probe into green 
fluorescent Rhodamine 110 in RUF units. As reported from the biological laboratory 
results, RFU values are different for the different devices. The sintered samples with 
space holder exhibited the highest value amongst the other devices, while the 
palladium wafers and the samples made by SCBD showed a similar performance as 
shown in Figure 4-14. The (Sc) samples were not tested because they yielded a very 
low area to mass(mm2/g) ratio (Table 4-2), which rendered them as poor performing 
devices.  
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Figure 4-14: Fluorogenic assay used to determine the catalytic properties of the 
Ti-[Pd] devices surface, as reported in (165) 
However, for these results to be more accurate they have to be normalised with 
respect to the mass of palladium deposited on the carrier, which is presented in Table 
4-2 in the previous section. The amount of palladium was deposited in the sintered 
devices was much higher than the amount of palladium deposited in the other 
processes. Hence, the efficiency of the devices was different and the ability to convert 
the non-florescence probe into a fluorescence Rhodamine was different as well, as it 
can be observed in Figure 4-15. 
 
Figure 4-15: Normalised RFU per g values 
compared against surface area/Pd mass ratio of each device, as reported in (165)  
 
0
1000
2000
3000
4000
5000
6000
7000
8000
9000
10000
S Si Sii Siii Siv SP PLD SCBD
R
FU
                                                                                     Palladium coating deposition 
98 
 
4.4.1 Reusability test 
A reusability study was performed to determine the durability of the palladium 
layer on the carrier overuse. Pd devices were washed in 5 mL distilled water to ensure 
the coating is clean. Then, a mixture of 2 mL fresh solution of Prodye at 100 µM in PBS 
(pH = 7.4) was added to the Pd devices and stirred at 250 rpm using a magnetic-stirrer. 
The test temperature was set to be 37 °C which is similar to the human body 
temperature. It was repeated for 5 cycles. Each cycle took 24 hours and the RFU signal 
was detected by Spectrofluorometry and reported as shown in Figure 4-16.  
 
Figure 4-16: Reusability study of catalytic deprotection of the surface to 5 cycles, 
as reported in (165) 
From the results presented in the chart above it is obvious that SCBD sample has 
the highest RFU value among the rest of the samples in the first cycle. However, in the 
second cycle the RFU value dropped to about 35% of its original value. The significant 
change of the RFU value could be because the coating was detached and turned into 
powder in the mixture instead of remaining attached to the carrier. On the other hand, 
sintered wafers and sintered samples with space holder exhibited the lowest RFU 
values in all the cycles.  
Sputtered samples showed a higher value than PLD samples. The change in each 
cycle was not significant for the sputtered samples, which is a proof that the adhesion 
of the palladium was strong enough to endure several cycles of conversion from 
prodrug to dye in the whole five cycles. 
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Table 4-3: XPS elemental study on all manufactured devices before and after the biological tests 
Sample 
series 
Before Biological tests (atomic %) (SD) After Biological tests (atomic %) (SD) 
Pd3d C1s O1s Na1s Ti2P N1s Pd3d C1s O1s Na1s Ti2P N1s Si2p 
S 75.325 
(0.095) 
26.156 
(13.977) 
20.552 
(13.596) 
------- ------- 6.659 
(2.508) 
2.535 
(0.655) 
60.25 
(7.870) 
20.900 
(9.095) 
------- ------- 3.671 
(1.879) 
16.971 
(4.367) 
Sx 36.105 
(9.525) 
33.943 
(5.866) 
18.931 
(14.348) 
3.370 
(2.970) 
5.790 
(3.470) 
7.010 
(1.876) 
6.120 
(9.428) 
44.907 
(9.857) 
28.995 
(8.843) 
4.151 
(2.740) 
8.845 
(3.390) 
-------- -------- 
  
SP 76.045 
(2.535) 
23.362 
(8.019) 
14.462 
(10.464) 
------- ------- 7.630 
(1.081) 
15.865 
(1.345) 
65.82 
(18.334) 
16.30 
(11.332) 
------- -------- 5.500 
(2.340) 
3.492 
(2.577) 
PLD 44.435 
(4.865) 
37.133 
(5.269) 
12.163 
(6.548) 
1.411 
(0.876) 
------- ------- 10.540 
(1.310) 
62.021 
(10.333) 
30.324 
(10.002) 
------- -------- 2.833 
(1.909) 
-------- 
SCBD 55.770 
(25.260) 
35.837 
(7.498) 
14.591 
(12.750) 
4.079 
(2.055) 
------- 8.831 
(3.045) 
4.825 
(3.925) 
36.83 
(12.977) 
34.595 
(13.474) 
3.836 
(2.899) 
23.105 
(16.775) 
------- -------- 
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To confirm the results obtained in the reusability test, XPS tests were conducted 
on the samples before they have been used in the biological test and after being used. 
The results are reported in Table 4-3 and the atomic percentage variation of Pd3D 
before and after the tests are presented in Figure 4-17. 
From the results, it is obvious that the sputtered samples had the highest atomic 
percentage of Pd3d before and even after being used in the catalytic fluorescence test. 
More than 76% of the coating was Palladium which is considered as a high percentage 
of Palladium deposited without being contaminated or changed to another alloy. Even 
Palladium wafers which were made from only palladium powder showed a percentage 
slightly lower than the sputtered sample due to the carbon present in the top layer as 
shown in Figure 4-17. Moreover, the wafers after the biological test showed that the 
palladium coating was covered with a high percentage of carbon and other elements.  
 
 
Figure 4-17: Presence of Pd3d before and after the biological tests. 
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Therefore, the results from SP samples confirmed the existence of Pd0 before the 
catalytic fluorescence test and even after being involved in the reusability test for five 
cycles.  
Furthermore, SEM images were obtained for the samples before being used in the 
test and after being used. The images obtained are presented in Figure 4-18. The 
sintered samples images showed a rough surface due to the grinding and polishing 
process after the sintering process. Also, the sintered with space holder samples 
showed a rough and porous surface. The surface for theses samples did not change or 
effect after the biological test. While samples were coated by sputtering (SP), pulsed 
laser deposition (PLD) and supersonic beam deposition (SCBD) exhibited a smooth 
and uniformed surface. These surfaces did not need any further treatments before the 
biological tests. However, the pulsed laser deposition samples exhibited small Pd 
droplets on the surface.   
From the images obtained, it was obvious there was some detachment of the 
palladium coating for the samples fabricated by sputtering (SP), pulsed laser 
deposition (PLD) and supersonic beam deposition (SCBD) after being used in the 
biological test. That confirms the results obtained from XPS test and reusability tests 
which exhibited some reduction of the device efficiency. However, as mentioned 
before, the sputtered sample appeared less pitted and scratched and consequently 
displayed the highest RFU value and the highest atomic percentage after the catalytic 
test as well.  
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Figure 4-18: SEM surface images of Ti-[Pd] devices manufactured using the different methods 
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To study the performance of the devices in biological conditions, cell cytotoxicity 
was examined. A549 lung cells were used for this test at the Cancer Research UK Centre 
to be examined with the sputtered devices and the prodrug. The cells were used at the 
beginning without any treatment to be the control of the study. And then the cells were 
incubated with the sputtered devices to check their cytotoxicity. Also, an inactive 
prodrug (POB-SAHA) was used with the cells. Furthermore, an active drug (SAHA) was 
examined with the cells. Finally, the sputtered device and the prodrug device was 
incubated together with the cells. The duration for each test was 3 days and the cell 
viability was obtained by the Prestoblue™ assay. The results are shown in Figure 4-19.   
 
Figure 4-19: Cell viability studies assessing the activation of prodrug (POB-SAHA) to 
antitumour drug (SAHA) in the presence of the SP Ti-[Pd] device, as reported in (165)  
From the chart, the control presents the cells being used and tested without any 
treatment. The sputtered devices were incubated with the cells and did not show any 
cytotoxicity and the cells were 100% viable and equal to the control percentage. 
Furthermore, an inactive prodrug (POB-SAHA) was incubated with the cells and did 
not exhibit any significant changes because the drug was inactive. 
When the inactive prodrug (POB-SAHA) and the palladium sputtered device were 
incubated together with the cells, the viability percentage of the cells dropped as low 
as the results obtained when the cells were treated directly with the active drug 
(SAHA) as shown in Figure 4-19. That confirmed that the sputtered device was 
working catalytically and activated the prodrug (POB-SAHA) to kill the cancer cells, 
confirming the hypothesis of this biological study.    
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5 Discussion 
5.1 Introduction 
In this chapter, all results obtained in this research will be discussed. A comparison 
between the results obtained in this project and the previously reported results done 
in the same areas of research will be presented.  
5.2 Ti and Ti alloys carrier 
Different manufacturing methods were considered in this research to fabricate Ti 
carriers and Ti alloys. A Powder metallurgy technique was used to manufacture the 
carrier due to the technique’s ability to control the parameters and the availability of 
the equipment and hardware. Furthermore, due to the high cost of Titanium powder, 
powder metallurgy, which is a very effective technique with low waste, could reduce 
the total manufacturing cost of the device (169). Also, its quick production allowed to 
concentrate on the control of the coating processes to find the optimal coating process 
required to apply the Palladium layer. Titanium powder was cold pressed and sintered 
with different sintering temperatures and durations. It was necessary to keep the 
oxidation to a minimum during the sintering process by creating a high-level vacuum 
in the furnace to obtain high purity of the carrier (169).   
Ti and Ti alloys draw huge attention in the implants research and biomaterial field 
due to their mechanical properties, high corrosion resistance and for not being 
cytotoxic in the human body (170). Titanium and its alloys were chosen to be a carrier 
in this research due to their biocompatibility (171,172).  
In the first batch Ti substrates were fabricated with the Palladium layer and 
sintered together, with a temperature below the melting point for both elements to 
avoid any alloying between them. It was necessary to control the temperature below 
the melting point to avoid this occurrence because Pd0 is required to activate the 
prodrug. 
Ti powder was cold pressed and then sintered at 1200°C in a vacuum ceramic tube 
furnace. The duration of the sintering process was different, for the substrate 
fabricated with Pd layer in the same step, and the substrates were used for applying 
Pd layer in further steps. Thus, the substrate fabricated with the Pd layer in the same 
                            Discussion 
105 
 
step left for a longer time in the sintering process (12 hours in this case) to allow the 
bonding between the powder particles become stronger. While, the substrates used 
for SP, PLD and SCBD were left only for 2 hours which is enough to form a solid 
substrate.  
Several analytical processes and tests were performed to identify the condition of 
the substrates. An XRD test was conducted to confirm there was no alloying between 
the Ti substrate and the Pd layer. In addition, an SEM test was performed to study the 
topography of the Pd layer. Furthermore, an EDS test was conducted to determine the 
elemental composition on the surface of the Ti-[Pd] devices.  
On the other hand, Titanium alloys in this research were manufactured by an Arc 
melting Technique. This technique was chosen due to the rapid cooling occurred 
during the melting process to enhance the stabilisation of β phase. β phase titanium 
alloys were considered due to their excellent mechanical properties. They exhibit high 
elasticity, wear resistance and hot and cold formability (173). Ternary alloys were 
designed using the DV-Xα cluster method. This method was reported by Moringa (174) 
and Abdel-Hady (166) and a 𝐵𝑜̅̅̅̅ -𝑀𝑑̅̅̅̅̅ diagram was used to get the relationship between 
elastic properties and the phase stability, where 𝐵𝑜̅̅̅̅  is the bonding strength between 
the alloying elements and Ti while 𝑀𝑑̅̅̅̅̅ value has a relation with radius of elements and 
electronegativity.  
Alloying elements used to design the alloys were Nb, Ta and Sn as they behaved as 
β phase stabilisers. Although Sn is considered an α phase stabiliser, when it is used 
with Nb in Ti alloys, the results showed that it could stabilise the β phase.  
Four different alloys were designed and fabricated. Since it was reported in the 
study presented by Takahashi et al. (175) that TiNbSn alloys were developed to 
overcome the issues of the presence of Ni in TiNi alloy and that biocompatibility of Ti, 
Nb, Ta and Sn is high, these elements were selected to design the alloys in this research. 
The alloying elements weight percentage was chosen to lower the transformation 
temperature. The four alloys were Ti30Nb4Sn, Ti35Nb4Sn, Ti37Nb6Sn and 
Ti35Nb14Ta. According to the 𝐵𝑜̅̅̅̅ -𝑀𝑑 ̅̅ ̅̅ ̅graph, these alloys were expected to have α+β 
phase or β phase after the arc melting process. According to the results obtained from 
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the XRD tests, the expected phases for the alloys were confirmed. The compositions 
were confirmed by EDS analysis.  
After fabricating the alloys, they were tested and analysed to determine the phase 
produced and, also to know the transformation temperature for these alloys. DSC tests 
were conducted to determine the transformation temperature for each of these alloys. 
From literature, reverse transformation temperature can be reduced by adding 
different stabilising elements such as Mo (176), Fe (177), Ta (59), Zr (178), and Si 
(179).  The alloys were tested heating up from -20°C to 250°C. Ti30Nb4Sn alloy 
exhibited a small peak around 79°C, while, by increasing the content of Nb to 35% 
another small peak appeared around 123°C. In addition, by increasing the Nb content 
to 37% and the Sn content to 6% an obvious peak appears around 43°C. For the 
Ti35Nb14Ta alloy, the DSC graph exhibited a peak around 30°C. These results agree 
with the results obtain by Takahashi et al. (175) so that by increasing the amount of 
Nb the transformation temperature decreased. Also, the increment of Sn content 
decreases the transformation temperature by 123°C for each 1%. The only exception 
in this data set is that the peak detected in Ti35Nb4Sn alloy before heat treatment was 
higher than the peak in Ti30Nb4Sn prior to heat treatment too. Both peaks were very 
weak. This could be explained by the peaks not being a transformation peak, but some 
other phase change or a much smaller energy level. Furthermore, the study shows that 
the quenched alloys had very weak transformation peak in the austenic transformation 
on cooling or even no peaks appear at all as shown in  
Figure 5-1. That means, that the small amount of α” is superseded by the dominant 
cubic (BCC) phase, not showing an austenic peak as transformation. 
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Figure 5-1: DCS curve of Ti-16Nb-4Sn quenched in iced water after solution 
treatment (175) 
In agreement with the above observation, XRD results obtained for all alloys 
before heat treatment exhibited only β phase peaks. Ti35Nb14Ta alloy displayed the 
highest intensity of the peaks when compared to other alloys. Ti35Nb4Sn showed a β 
peak at 83°, while this peak had lower intensity when the content of Nb was decreased 
to 30% and, also when it was increased to 37% but also increasing Sn content to 6%.  
In this research, heat treatment was employed to either reduce the transformation 
temperature or stabilise the β phase with low transformation temperature. The alloys 
were encapsulated to avoid any oxidation during the heat treatment and heat treated 
in a ceramic tube furnace. They were heated to 1200 °C for 24 hours and then quenched 
in ice water. The work done by Takahashi et al. found that the phase transformation 
was influenced by heat treatments in TiNbSn alloys (175). Wang et al. reported that 
the heat treated TiNbSn alloy stabilised β phase at room temperature (180). DSC tests 
were repeated to determine the influence of the heat treatment on the transformation 
temperature. For Ti30Nb4Sn peaks disappeared after the heat treatment, while 
Ti35Nb4Sn exhibited a peak around 48°C which means the transformation 
temperature dropped 75°C from 123°C. On the other hand, Ti37Nb6Sn alloy 
transformation temperature increased from 43°C to 58°C after heat treatment. The 
alloy with 14% of Ta did not show any peaks after the heat treatment, it could be 
because the transformation temperature of the alloy dropped below the test 
temperature range.        
XRD tests were repeated as well to determine the phases of the alloys. Ti35Nb4Sn, 
Ti37Nb6Sn and Ti35Nb14Ta exhibited only β phase peaks, while, Ti30Nb4Sn alloy 
showed α”+β phase as expected during the design stage.  
Furthermore, mechanical tests were conducted to explore the mechanical 
properties of the alloys. In addition, a hardness test was performed to identify the 
influence of alloying elements and heat treatment on the hardness of the alloys. The 
hardness test of the alloys before the heat treatment showed hardness values of 304, 
306, 312 and 307 HV for the alloys Ti30Nb4Sn, Ti35Nb4Sn, Ti37Nb6Sn and 
Ti35Nb14Ta respectively. By increasing Nb content from 30% to 35%, hardness 
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increased from 304 to 306 HV. By increasing Nb content up to 37% and Sn content 
from 4% to 6% the hardness value also increased to 312 HV. The work has been done 
by Moraes et al. (74) on Ti30NbxSn (x=2,4,6 and 8 wt%) reported that Ti30Nb4Sn has 
a hardness value around 280 which is close to the value obtained in this study. They 
also claimed that the alloy with Sn content of 2 and 4 %wt did not exhibit a strong effect 
in the hardness value while when the content increased to 6%wt, the alloy showed the 
lowest hardness value. On the other hand, by reducing Sn content to 0% and by adding 
14% of Ta the hardness value only increased from 306 to 307HV.    
After the heat treatment, the hardness value for the alloys increased. Ti30Nb4Sn 
alloy hardness value increased from 304 to 319 HV and Ti35Nb4Sn increased from 306 
to 318 HV. Ti37Nb6Sn alloy hardness value increased from 312, which was the highest 
hardness value before heat treatment, to 332 HV while Ti35Nb14Ta exhibited the 
highest hardness value with 339 HV after heat treatment. A study conducted by Lopes 
et al. (181) concluded that TiNb alloys are very sensitive to the changes in 
microstructure occurred by heat treatment processes. Also, due to this sensitivity the 
elastic modulus and Vickers hardness affected by heat treatment which agrees with 
the results obtained in this study.  
The Young’s moduli of all alloys after heat treatment were approximately between 
14 GPa and 17GPa, which is very close to the Young’s modulus of cortical bone 
(reported as approximately 12 to 14 GPa)(182,183). This result confirms that the 
designed ternary alloys allowed a decrease in stiffness and therefore their properties 
are similar to those of bone.   
These alloys exhibited superelastic behaviour at room temperature and that was 
confirmed by the cyclic test performed. The study conducted by Kim et al. (59) found 
that TiNb alloy with a content of Nb 25.5-27 at % showed superelastic behaviour at 
room temperature. It is therefore possible to obtain superelastic behaviour in the 
alloys produced in this study with Nb content more than 30wt %.   
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5.3 Palladium coating 
There are many coating processes to apply thin films. However, not all of these 
processes are suitable to be used in this research work. To filter these processes and 
select the optimal process to be used, a list of requirements has to be taken into 
consideration. These requirements are: 
I. The applied coating film has to be non-alloyed with the carrier material. 
II. A Minimal mass of coating material (Pd) can be applied. 
III. Able to apply highly uniform coatings. 
IV. The coating film has to be free of toxic constituents and of high purity on the 
metallic surface. 
V. Biocompatibility of the materials and elements used in the processes.  
VI. The process has to be time and cost effective.       
Different coating processes were surveyed and examined for suitability in the 
production of a Pd surface ready for the catalytic reaction. Four coating processes were 
shortlisted due to them meeting the requirements and used in this research to find the 
optimal process to apply Pd coating.  These processes included powder metallurgy, 
magnetron sputtering deposition, pulsed laser deposition and supersonic beam 
deposition process. They were chosen to utilise the minimum amount of palladium 
required to reduce the production cost of the device. In the meantime, maximising the 
surface area for an effective catalytic reactivity when in contact with the Pd-sensitive 
molecules. Applying the catalyst, in this case Pd, onto a carrier has many reasons. One 
of the reasons as mentioned before is to reduce the quantity of palladium used. Also, it 
can increase the size of the device but still be handled by the surgeons during the 
implantation process and remain easy to be removed. In addition, it would increase 
the devices catalytic bioactivation activity.  
A major consideration for the device was to control the surface area, minimising 
the weight to volume ratio and obtaining a high purity of the catalyst applied. It was 
confirmed that all the four deposition processes used in this research achieved to 
deposit Pd0, as confirmed by XRD results presented in chapter 4. Additionally, there 
was no alloying between Ti substrates and the deposited palladium, and the palladium 
was retained in its cubic form. However, the devices manufactured by powder 
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metallurgy technique presented TiO2 on the top surface of the devices. TiO2 occurred 
because of the presence of NaCl in the sintering stage through a chloride route as 
explained in the study presented by Sun et al. (167). Therefore, besides the poor 
performance with regards to its surface area, the large Pd mass employed to form the 
coating and the obvious decreased reusability potency beyond the 3rd cycle, these 
devices were discarded for the application.  
Regarding minimising the quantity of palladium deposited on the Ti substrate, 
magnetron sputtering, pulse laser and supersonic cluster beam deposition processes 
achieved to deposit the thinnest of the coating Pd0 layers and that was demonstrated 
by the thickness analysis obtained by XRF, FIB/TEM, SEM, and AFM tests performed in 
this study. Therefore, these results make these methods the most cost-effective way of 
creating catalytic-active devices.  
The XPS results for the devices fabricated by powder metallurgy technique but 
without a substrate exhibited the presence of a considerable C layer (C1s peak), which 
made them less reactive to the catalytic deprotection. These devices were fabricated 
as wafers only without being carried on a substrate, with the consequent higher use of 
Pd powder as raw material as it was necessary to have sufficient amount of palladium 
to form a solid wafer that can be handled. The production cost of the devices was the 
highest among all other devices due to the high cost of palladium. Furthermore, these 
devices performed poorly in the reusability tests, failing to retain any catalytic potency 
beyond the 2nd cycle. These reasons make them less attractive for the application.  
Devices fabricated by magnetron sputtering, pulsed laser and supersonic cluster 
deposition methods exhibited a Pd3d peak on the XPS spectra. This peak confirmed the 
chemical state of metallic palladium in these devices, without being alloyed or changed. 
These peaks present different intensity for each device and the sputtered devices 
showed the highest intensity in all the other devices.    
The result from the catalytical activated fluorogenic studies correlated well with 
the on-surface tests performed on the devices. Despite the supersonic cluster beam 
deposition device exhibiting the largest initial fluorescence signal among other 
devices, the surface SEM images obtained after the biological test presented clear signs 
of chipping and detachment, which depleted its catalytic potency. This was confirmed 
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with the results from the reusability test, with a marked detriment in its fluorogenic 
signal after the 1st cycle, and by the surface exploration after those tests. Concurrently, 
it was observed that the devices manufactured using pulse laser deposition method 
showed a plateaued fluorogenic signal after the 1st cycle, compared to sputtered and 
supersonic cluster beam devices. These results showed depletion in catalytic 
deprotection activity after the 2nd cycle and are symptomatic of poor integrity of the 
substrate and its coating.  
The sputtered devices reported higher fluorogenic signals, sustained over the 
reusability tests and, given the smaller quantity of palladium used, their production is 
therefore more cost-effective. Consequently, it was concluded that the magnetron 
sputtering method was the best manufacturing route to functionalise the devices in a 
facile, reliable manner. This method allowed the preparation of catalyst-loaded devices 
with good reusability results, probably due to the good adhesion strength at the Pd/Ti 
interface and good material continuum. Therefore, these sputtered devices were 
selected for further in vitro cellular studies that can be found in the published paper 
(165).  
The results obtained in this study fulfill the design and manufacture specifications 
set at the start of the project, having achieved a set of Ti-[Pd] devices suitable for 
implementation and the chemical activation of an anticancer treatment. 
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6 Conclusions  
This research was divided into three aspects. The first aspect was to study the 
potential manufacturing processes to fabricate a catalyst carrier. The second aspect 
was to design and fabricate biocompatible superelastic β phase titanium alloys. The 
third aspect was to deposit a catalyst coating on the carrier. The three aspects were 
planned and designed to create a framework and protocol to manufacture the 
activating medical device.  
In the first stage of this research, different potential manufacturing processes were 
investigated. Additive manufacturing, Metal Injection moulding, Powder Metallurgy 
technique and Arc Melting methods were considered. Additive manufacturing was 
discarded because of the low speed of this method, the high cost of the process and the 
high wastage of material produced from this method. In addition, this process requires 
using fine spherical titanium powder which is considered costly compared to other 
powders. Metal injection moulding process has advantages such as the flexibility of the 
process, and the ability to fabricate complex part. However, it is very costly to create a 
cast and the process poses several health and safety challenges because it requires to 
melt a metal. Hence, Powder Metallurgy technique was selected to be the first 
manufacturing method used to fabricate the catalyst carrier due to its low cost, 
simplicity, availability of the equipment and suitable metal powders. Searching and 
exploring more manufacturing processes for Ti alloys showed that the arc melting 
process was an excellent process to produce Ti alloys. Therefore, Powder metallurgy 
and arc melting process were used in this research to fabricate the catalyst carriers in 
the second stage.  
Furthermore, coating and joining processes were investigated to find the optimal 
process to apply the palladium coating film on the carriers. Soldering and brazing 
process, welding, wet chemistry processes and using negative moulds were evaluated. 
These processes were not suitable to achieve the aim of this research for different 
reasons. Soldering and brazing process was rejected because the process was not 
appropriate to join different materials as well as the welding process. Chemical vapour 
deposition was not taken forward in this research because it requires high 
temperatures which can affect the properties of the substrate. Also, this process 
produces toxic and harmful gases due to the materials used. Another major reason to 
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discard CVD was the impurity of the deposited film due to the gases involved in the 
process. In addition, wet chemistry processes such as electroplating and electroless 
plating processes require ions exchanged between the solution and the substrate 
which will not give a Pd0 coating. The negative mould was discarded because it did not 
produce a continuous surface due to high pressure applied to the powder. Therefore, 
Powder metallurgy, Sputtering, Supersonic Cluster Beam Deposition and Pulsed Laser 
Beam deposition were considered because they overcome these issues.  
In the second stage, Ti powder was used as the initial element to fabricate the 
catalyst carrier due to its biocompatibility, corrosion resistance and excellent 
mechanical properties. The samples were produced by applying a cold uniaxial load 
and then the samples were sintered in a vacuum ceramic tube furnace. The furnace has 
reached a level of 10-5 mbar vacuum and the samples were left for two hours at a 
temperature of 1200 °C. Then, it was left in the furnace to cool down at the same rate 
of heating. The samples were polished and prepared according to the recommended 
procedure for Ti and Ti alloys. These substrates were used to examine the deposition 
processes in further stages of this research.  
An XRD test was conducted on these Ti-[Pd] to examine the phase produced and 
ensure there was no oxidation or contamination. The results obtained confirmed that 
Ti substrates were pure and not contaminated and that the Pd was in its non-alloyed 
state.  
Also, four different alloys were designed and manufactured. Ternary alloys were 
designed using the DV-Xα cluster method to obtain β phase titanium alloys. Three 
alloying elements were used to obtain stable β phase in these alloys. Niobium, Tin and 
Tantalum were opted to be the alloying elements due to their biocompatibility and the 
ability to stabilise the Ti β phase. Alloys were fabricated as Ti30Nb4Sn, Ti35Nb4Sn, 
Ti37Nb6Sn and Ti35Nb14Ta, which were expected to be β and β+α phase alloys. These 
alloys were manufactured by arc melting technology and then they were heat treated 
and quenched in ice water to stabilise the transformation phase and reduce the 
transformation temperature. The samples were encapsulated in quartz tubes and 
heated to 1200 °C for 24 hours before the quenching step took place. The alloys after 
the heat treatment were cut and prepared to be examined with different analysing 
methods. Samples were prepared for testing to obtain the mechanical properties of the 
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alloys. Samples were used for EDS, SEM, XRD, DSC and hardness tests. The samples 
were prepared by mounting them using cold mounting resin and then they were 
polished and etched with Kroll’s reagent. 
The EDS tests exhibited the same percentages desired of each alloying element in 
the samples. The results obtained confirmed that the samples had no contamination or 
unwanted elements. Also, SEM and optical results showed β phase grains. Some 
dendritic formations were present on the top of the samples. They occurred due to the 
rapid cooling during the arc melting process and disappeared after heat treatment.  
The DSC tests results for the alloys showed some small peaks in the martensitic 
transformation at 79°C, 123°C, 43°C and 30°C prior to heat treatment and after heat 
treatment no peak, 48°C, 58°C and no peak for the alloys Ti30Nb4Sn, Ti35Nb4Sn, 
Ti37Nb6Sn and Ti35Nb14TA respectively. However, there were no obvious peaks in 
the austenitic transformation.  
XRD results before the heat treatment exhibited only β phase for all the alloys. 
While after the heat treatment Ti30Nb4Sn alloy showed α”+β phase and the other 
alloys remained the same without any change in the transformation phase.  
Mechanical tests showed these alloys have a similar stiffness to that of bone and 
are superelastic at room temperature, demonstrating that it is possible to fabricate a 
superelastic alloy with Nb content of 30% or more. In addition, the hardness test 
showed an increment in the hardness value after the heat treatment and with the 
increment of Nb content in the alloy.     
In the third stage of this research, five different coating processes were 
investigated and applied to obtain the optimal coating process. The first manufacturing 
process used was the powder metallurgy technique followed by a sintering process. 
Palladium wafers were produced. The samples were used in the biological test without 
any further treatment. The results yielded a poor performance with the prodrug. Also, 
a layer of palladium powder was added on the top of Titanium layer and sintered was 
performed.   
In the second manufacturing process, a powder metallurgy technique with space 
holder was applied. Two different space holders were investigated. Ammonium 
bicarbonate was used as the first space holder to obtain a rough surface which could 
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increase the surface area of the catalyst. The calcination process did not successfully 
remove the amount used in the sample preparation. Therefore, NaCl was used as a 
space holder to avoid using the calcination process and the samples washed to remove 
the space holder instead. However, samples fabricated with NaCl space holder 
generated TiO2 onto the Ti-[Pd] carrier, which encouraged us to explore other more 
effective deposition processes. These samples also exhibited poor activation of the 
prodrug during the biological test. 
The third process used was a Magnetron Sputtering deposition. Pure palladium 
(Pd0) was deposited on the substrates with different thicknesses without alloying 
between Pd and Ti substrate. The thickness of the coating was measured with several 
measurement methods (i.e. AFM, XRF, FIB/TEM). The results obtained showed that the 
thickness of the coating is adequate to activate the prodrug and there was no waste of 
the material deposited.  
In the fourth method, pulsed laser deposition was employed to apply a thin film of 
Palladium onto the substrate. The results obtained from the characterisation tests 
demonstrated that it is possible to deposit a thin film of palladium suitable for this 
application. The coating was palladium in its metallic state without being alloyed or 
changed. In addition, the sample showed accepted results in the biological test.  
Finally, the fifth method produced another sample coated by supersonic cluster 
beam deposition. These samples were cost effective due to the thickness of the coating 
and the material deposited. XPS results for this sample showed that Pd0 was 
successfully deposited on the substrate and the thickness was measured with XRF 
confirmed that the desired thickness was achieved.                    
The catalytical activated fluorogenic test showed that supersonic cluster beam 
deposition sample achieved the highest results among the other samples. However, 
after the reusability test, the sample lost its activity more than 50% of the first cycle, 
while the sputtered sample showed the best results throughout.  
In summary, the first aspect of this research helped to understand the potential 
manufacturing and deposition methods can be used to fabricate the medical device 
carrier required.  The second stage showed that it is possible to fabricate β phase 
titanium alloys with satisfactory mechanical properties and biocompatibility to be 
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used as a catalyst carrier. Furthermore, the third aspect of this research was 
successfully performed to find the optimal deposition method to deposit Pd0 onto the 
carrier and trigger the activation of a prodrug. 
The results obtained in this research will help to reduce the number of death cases 
occurred due to the lack of targeted cancerous treatment and increase the surviving 
cases. Furthermore, the devices designed and manufactured in this research study will 
reduce the side effects of other cancer treatment. The devices will be effective only in 
the cancer cells location without affecting the healthy cell for the patients.    
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7 Future work 
This chapter highlights some aspects that could be taken into consideration to 
develop and continue this research further. The aspects include some ideas for the 
manufacturing techniques, design of the device and also different alloys elements.  
These ideas are listed in the following points: 
1. In this research different coating processes were evaluated, examined and used 
to find the optimal coating process suitable for reaching the desirable aim. 
However, alternative processes (e.g. ALP, grafting, etc.)  were not used during 
the experimental work due to the availability of the equipment or the time limit 
of the research.  
2. Increasing the surface area, by making the substrate with an extensible surface 
activated by changing the temperature, would increase the contact area 
between the device and the prodrug. This can be achieved through the use of 
shape memory alloys.  
3. Introducing different biocompatible alloying elements for the fabrication of the 
substrate could improve the ability of the device to perform as a shape memory 
material. Changing the percentage for each element could improve the material 
elasticity and the shape memory effects.  
4. Furthermore, shape memory polymers can be used as an alternative substrate 
when the target organ is not load-bearings provided they are biocompatible and 
have the ability to adhere to metallic materials (i.e. Palladium) onto them.   
5. Use different shapes and forms for the carrier to increase its surface area, for 
example, a double-sided disc or a sphere. 
6. Conducting different heat-treatment procedures to adjust the transformation 
temperature of the alloys. Using different temperatures, duration and 
techniques for the heat treatment process will change the transformation 
temperature to bring it closer to that of the human body. For example, 
quenching the alloys in different media such as oil or ice instead of water.  
7.  Surface preparation of the substrates before applying the coating film with 
different techniques. The substrates in this research were prepared by grinding 
them manually and then automatically polished to a smooth surface before they 
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were coated. Hence, electro-polishing technique could be used to improve the 
finished surface of the substrate. 
8. Applying a coating film onto the palladium layer to protect it and avoid 
detachment of the palladium particles, maintaining the catalytic properties of 
the coating over use. A biocompatible film of a porous polymer can be a useful 
coating film to prevent losing the palladium particles after implanting the 
device in the human body.  
These ideas presented in this chapter can help to improve the results obtained 
in the stage of the research and open the door for future development. 
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 Appendix 1 
Detailed manufacturing procedure for Powder metallurgy samples. 
1. Clean the furnace tube from any contamination, clean by washing the tube 
with soap and water.  
2. Run the furnace for 30 minutes with a temperature above 100 °C to remove 
any moisture in the tube after washing. 
3. Prepare the pressing mould by cleaning all the parts from any previous 
materials and remove any rust or contamination. 
4. Prepare the Titanium powder to make one sample as calculated.  
5. Pour the powder into the pressing mould using a funnel to direct the powder 
into the bottom of mould. 
6. Press the Titanium powder by pressing the mould plunger manually to make it 
firm and levelled. 
7. Add the Palladium powder on the top of Titanium. 
8. Press the powders with approximately 20 kN.  
9. Remove the green body from the mould by pressing the mould plunger to the 
opposite direction. 
10. Check the total weight of the green body and record it. 
11. Use an alumina boat to insert the green body into the furnace tube. And install 
it in the centre of the furnace tube.  
12. Insert the ceramic shells to keep the temperature controlled in the furnace.  
13. Install the furnace fitting to close one end and get the other end ready to be 
connected to the vacuum pump hose. 
14. Connect the vacuum pump hose and make sure all the connections are correct 
and sealed. 
15. Start the vacuum pump to reach a vacuumed space in the furnace to the level 
of e-5. 
16. Start the furnace to reach 1200°C, in two steps, from room temperature-600 
with speed 5°C per minute and then 600- 1200°C with speed 3°C per minute. 
17. Hold that temperature for 2 hours to sinter the green body. 
18. After 2 hours the furnace starts cooling down to reach the room temperature. 
19. Switch off the vacuum pump and the furnace.  
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20. Remove the fittings to be able to reach the boats.  
21. Take the carrier out of the furnace and check the total weight of the green 
body after sintering. 
22. Polish the catalyst carrier. 
23. Wash the catalyst carrier with alcohol, ethanol in this case, to remove any 
remaining water or moisture.   
24. Check the weight of the catalyst carrier to record the data. 
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Appendix 2 
Detailed manufacturing procedure for arc melted samples 
1. The powders were mixed and pressed in the same way as the powder 
metallurgy sample to prepare the green body. 
2. The chamber and the copper stage were cleaned by acetone. 
3. The green body  was placed on the copper stage. 
4. A small piece of zirconium metal was placed in one of the spherical slots on 
the stage. 
5. The copper stage was attached to the chamber and closed securely. 
6. The cooling system which is connected to the copper stage was operated. 
7. The argon gas was open and adjusted the pressure to maximum of 2 bar. 
8. The arc melting machine was switched on. 
9. The vacuum pump was operated and opened the vacuum valve and hold for 5 
minutes. 
10. After the vacuum was closed and the gas valve was opened until the gas 
pressure in the chamber reached 1 bar. 
11. The gas valve was closed, and the vacuum valve was opened fully and hold for 
5 minutes again. 
12. The same flushing process was repeated for 5 times.  
13. After completing the flushing process and the gas valve was open until the gas 
pressure reached 0.5 bar and held during the melting process. 
14. The melting current was set to 5 and the safety cover was closed. 
15. The melting electrode was located near the zirconium metal and the arc was 
started to melt it. 
16. The arc was switched off and left for 10 seconds to absorb the moisture or any 
contamination in the chamber. 
17. The electrode was located near the green body and the start melting green 
body until it was totally melted. 
18. The green body left to cool down under the gas atmosphere for 7 minutes 
before the air valve was opened. 
19. The stage was disconnected, and the green body was removed. 
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20. The green body was flipped on the other side and the same procedure and 
steps were repeated for 6 times. 
21. After the melting process was completed the casting stage was connected to 
the chamber and the molten green body was placed on the stage. 
22. The same flushing procedure was repeated for 5 times and the starting 
melting of the zirconium metal was repeated. 
23. The electrode was located on the corner of the ingot and the arc was started 
until the material start to melt the green body. The current was sometimes 
increased to 8 to allow the material to melt completely.  
24. The casting valve was opened to allow the molten metal to flow into the 10 
mm cast tube until the whole ingot is melted and cast in the tube. 
25. The arc switched off and left to cool down before removing the green body 
from the chamber. 
26. After that, the casted green bodies were cut using the slow speed saw into a 
slice of 2 mm thick.  
27. The cut green bodies were polished to have a smooth and flat surface and 
ready for the deposition processes. 
 
 
